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                                     INTRODUCTION 
Neuropharmacology is one of the branches of Pharmacology that encompasses many 
aspects of the nervous system from single neuron manipulation to entire areas of the 
brain, spinal cord and peripheral nerves. It deals with the study of how drugs affect 
cellular function in the nervous system.(1,2)It brings to understand how human 
behaviour and thought process are transferred from neuron to neuron and how 
medications can alter the chemical foundation of these processes. 
Two main branches of Neuropharmacology: 
1. Behavioural Neuropharmacology 
2. Molecular Neuropharmacology 
Behavioural Neuropharmcology: 
It focuses on the study of how drugs affect human behaviour including the study of 
how drug dependence and addiction affect human behaviour.(3) 
Molecular Neuropharmacology: 
It focuses on the study of neurons and their neurochemical interactions. 
Both fields are interconnected. These are concerned with the interactions of 
neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second 
messengers, Co-transporters, ion channels and receptor protein  in the central and 
peripheral nervous system. 
With the help of neurochemical interactions researchers are developing drugs 
to treat many different neurological disorders including pain, neurodegenerative 
diseases such as Parkinson’s disease and Alzheimer’s disease and Psychological 
disorders such as addiction. 
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BASIC PRINCIPLES OF THE NEUROPHARMACOLOGY 
Neurological diseases affect a large fraction of the general population.The 
pathophysiological mechanisms underlying most brain disorders are poorly 
understood. Many CNS disorders have a genetic basis.The elucidation of mutations in 
familial forms of these diseases contribute to our understanding of their 
pathophysiology.(4) 
Brain diseases are classified as follows: 
Psychiatric diseases 
 Neurodevelopment disorders (Autism, Rett syndrome, Attention deficit disorders) 
 Anxiety (Panic, Generalized anxiety, Phobia, Post traumatic stress disorder) 
 Mood disorders (Depression, Bipolar disorder) 
 Schizophrenia, Tourette’s  Disease 
 Drug dependence 
Neurological diseases 
 Stroke and Ischemia 
 Brain lesions (Trauma, Tumors, Infections) 
 Epilepsy 
 Chronic pain 
 Sleep disorders 
 Movement disorders (Dystonia, Tremors) 
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Autoimmune diseases 
 Multiple Sclerosis 
 Myaesthenia gravis 
Neurodegenerative diseases 
 Alzheimer’s disease 
 Parkinson’s  disease 
 Huntington’s disease 
 Amyotropic lateral sclerosis 
 Prion disease (Crutzfeld Jacob disease) 
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NEURODEGENERATIVE DISEASES 
The term ‘Neurodegenation’ means progressive loss of structure or function of 
neurons. Neurodegenerative diseases are group of illness with distinct clinical 
phenotypes and genetic etiologies characterized by progressive and irreversible loss of 
neurons from specific regions of the brain.(5)Parkinson’s disease, Alzheimer’s and 
Huntington’s disease occurs as a result of neurodegeneration. WHO data suggest that 
neurological and psychiatric disorders are important and growing cause of morbidity. 
The magnitude and burden of mental, neurological and behavioural disorders is huge, 
affecting more than 450 million people globally. According to the Global Burden of  
Disease report, 33 percentage of years lived with disability and 13 percent of 
disability-adjusted life years are due to neurological and psychiatric disorders, which 
account for four out of the six leading cause of years lived with disability.(6) 
Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease account for 
a significant and increasing proportion of morbidity and mortality in the developed 
world.As a result of increased life expectancy and changing population demographics, 
neurodegenerative dementias and neurodegenerative movement disorders are 
becoming more common.(7,8) 
 
The most important factors related to neurodegeneration are oxidative stress, 
excitotoxicity, energy metabolism and ageing, environmental triggers and genetics.   
Oxidative stress and excitotoxicity are two important targets for neuroprotective 
therapy. 
 
Oxidative stress: 
It is caused by excessive production of reactive oxygen species. The brain 
utilized mitochondrial oxidative phosphorylation for generating ATP, the key 
molecule of energy. Under certain conditions highly reactive oxygen species may be 
generated as side products of this process. ROS attack many key molecules such as 
superoxide dismutase, catalases as well as antioxidants involved in antioxidant 
defense mechanisms. 
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Excitotoxicity: 
The phenomenon of Glutamate accumulation in the neurons is called 
excitotoxicity. Calcium overload is the essential factor in this process, which leads to 
cell death. It causes neurotoxicity by increased release of glutamate, activation of 
proteases and lipases, which disrupt mitochondrial membrane and activation of 
endothelium leads to activation of nitric oxide synthase inturn, produce NO. Its high 
concentration leads to produce free radicals.(9) 
 
 
 
 
                                                               FIG. NO: 1 
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The important characteristic of neurodegenerative disorder is that particular 
anatomic or physiologic system of neurons is selectively affected. Degenerative 
diseases are classified into individual syndromes based on clinical aspects and 
anatomical distribution of lesions.(10) 
 
Table no.1:-COMMON NEURODEGENERATIVE DISORDERS. 
 
REGION 
AFFECTED DISEASE 
MAIN 
FEATURES 
PREDOMINANT 
PATHOLOGY 
 
Cerebral 
cortex 
 
 
Alzheimer’s disease 
 
Pick’s disease 
 
Progressive 
senile 
dementia. 
Pre-senile 
dementia. 
 
 
Cortical atrophy, senile plaques 
(neuritis), neurofibrillary tangles, 
amyloid angiopathy. 
Lobar cortical atrophy, ballooning 
degeneration of neurons. 
 
Basal 
ganglia 
and 
Brain stem 
 
Huntington’s disease 
 
 
 
Parkinson’s disease 
 
Progressive 
dementia with 
choreiform 
movements. 
Abnormalities 
of posture 
movements. 
 
Atrophy of frontal lobes fibrillary 
astrocytosis. 
 
 
Aggregates of melanin containing 
nerve cells in brain stem, 
intracytoplasmic neuronal 
inclusions (Lewy bodies). 
 
Spinal cord 
and 
cerebellum 
 
Cerebellar cortical 
degeneration 
 
Olivopontocerebellar
Atrophy 
 
Spinocerebellar 
atrophy 
 
 
Progressive 
cerebellar 
ataxia. 
Cerebellar 
ataxia. 
 
Gait ataxia. 
Dysaetheia. 
 
Loss of purkinjee cells in cerebral 
cortex. 
 
Combination of atrophy of 
cerebellar cortex, inferior olivary 
nuclei and pontine nuclei. 
Degeneration of spinocerebellar 
tracts, peripheral axon myelin 
sheaths. 
Motor 
neurons 
 Amyotropic lateral 
sclerosis 
Syndromes of 
muscular 
weakness and 
wasting 
without 
sensory loss. 
 
Progressive loss of motor neurons 
both in cerebellar cortex and in the 
anterior horn of spinal cord. 
Werdning-Hoff man 
disease 
Spinal 
muscular 
atrophy in 
infants. 
Loss of motor neurons, 
denervation, atrophy of muscles. 
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PARKINSON’S DISEASE 
 Parkinson’s disease is a common and debilitating age-associated human 
neurodegenerative disorder characterized by a progressive loss of dopaminergic 
neurons in the substantia nigra pars compacta and degeneration of projecting nerve 
fibres in the striatum which leads to extrapyramidal motor dysfunction.(11)It was first 
documented by James Parkinson and it called so in 1817 as the “Shaking Palsy”an 
essay written by him. 
EPIDEMIOLOGY: 
 Parkinson’s disease is the second most common age-related neurodegenerative 
disorder. It develops much less frequently than Alzheimer’s disease ranging from 
0.1%-5% annually.(12) PD increases with age in both men and women but the rate in 
men exceeds that women by two-fold.(13) Worldwide estimates vary 15/100,000 in 
China, 657/100,000 in Argentina, 100-250/100,000 in North America and Europe. PD 
is more common in white people in Europe and North America and lower rates in 
China, Nigeria and Sardinia. 
Its prevalence is 1% among population over 65years and 2% over 80years.The 
annual incidence rates for PD ranges from 110-330/100,000 individuals over age 
50(14) and after age 80years the incidence rate increases to 400-500 
individuals/100,000 annually. Among persons over age 65 the prevalence of 
Parkinson’s disease has been estimated at 1800 per 100,000 (1.8%) individuals, 
increasing from 600 per 100,000(0.6%) for persons between the age of 65 and 69 to 
2600 per 100,000 (2.6%) for those 85 to 89 years.(15) 600, 000 to 1 million individuals 
in the United States have Parkinson’s disease, and approximately 70, 000 develop the 
disease each year. Risk factors related to PD are ageing, head trauma and declining 
oestrogen levels. 
ETIOLOGY: 
The specific etiology of Parkinson’s disease is not known. Epidemiological 
studies indicate that a number of factors may increase the risk of developing 
Parkinson’s disease. Both genetic and environmental factors have been implicated as 
a cause of Parkinson’s disease.(16) 
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Environmental factors: 
A number of exogenous toxins have been associated with the development of 
Parkinson’s disease such as pesticides, herbicides, trace metals, cyanide, and lacquer 
thinner, organic solvents, carbon monoxide and carbon disulphide. 
The most important toxin related to the pathogenesis of Parkinson’s disease is 
1, 2, 3, 6-methyl phenyl tetrahydropyridine (MPTP). It is a byproduct of illicit 
manufacture of synthetic meperidine derivative. MPTP induces toxicity by (17,18) 
 Its conversion in astrocytes to the pyridinium ion (MPP+) in a reaction 
catalysed by mono oxidase type - B (MAO-B). 
 MPP+ is then taken up by dopamine neurons and causes a mitochondrial 
complex-I defect similar to that of Parkinson’s disease. 
Genetic factors: 
Genetic factors play an important role in the pathogenesis of Parkinson’s 
disease.Genes responsible for familial Parkinsonism is α-synuclein, parkin, UCHL1 
and DJ1.(19) 
α-synuclein is a small flexible monomeric protein of 140 aminoacids.It is 
abundantly expressed in the nervous system in which it is concentrated in pre-synaptic 
terminals. It is widely expressed in various brain regions(20) including neocortex, 
hippocampus, dentate gyrus, olfactory bulb, thalamus and cerebellum and also in the 
amygdala and nucleus accumbens.Its normal function is unknown but it may have a 
role in synaptic vesicle transport and preserving synaptic plasticity.(21) 
Mutation in the α-synuclein causes fibrillogenesis, leading to increased self 
aggregation of protein and finally forms lewy bodies.(22) 
Parkin is a protein encoded by PARK2 gene. It is a part of the ubiquitin-
proteosome system that mediates the targeting of proteins for degradation.(23) 
Mutations in parkin could result in the accumulation of misfolded substrate 
proteins in the endoplasmic reticulum, resulting in cell death. 
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The important factors related to pathogenesis of Parkinson’s disease are 
 Ageing 
 Oxidative stress 
 Glutathione depletion 
 Nutritional deficiency 
 Metals such as Iron 
 
Ageing: 
 The risk of Parkinson’s disease is clearly age dependent. 
 As age increases loss of striatal dopamine and loss of dopamine cells in 
substantia nigra occurs.(24) 
 Due to increase in age the antioxidant defense system get impaired, which fail 
to scavenge free radicals produced during oxidative phosphorylation ,attack  
mitochondrial membrane which further leads to cell death. 
Oxidative stress: 
Oxidative stress contributes to the cascade leading to dopamine cell degeneration in 
Parkinson’s disease. Oxidative stress hypothesis refers a imbalance between 
formation of hydrogen peroxide and oxygen derived free radicals such as hydroxyl 
ion (OH-) and superoxide radicals (O2-) can cause cell damage due to chain reaction of 
membrane lipid peroxidation.(25)In brain substantia nigra is more vulnerable to 
oxidative stress than other regions. Its unique features are as follows 
 It contains high content of dopamine which consequent to the high density of 
dopaminergic neurons. Dopamine has a  strong tendency to spontaneously 
breakdown into oxidant metabolites by autooxidation most reactive               
among these autometabolites are 6-hydroxydopamine quinone and dopamine 
aminochrome.(26) Dopamine’s oxidative breakdown can be accelerated by free 
iron or by other redox active elements such as copper, zinc or manganese.(27) 
 High content of iron concentrated in substantia nigra’s zona compact a which 
becomes most damaged in Parkinson’s disease. When iron reaches such higher 
concentrations in cells it can escape  buffer control by ferritin and other iron 
binding proteins which is then catalytically convert hydrogen peroxide to 
generate highly reactive hydroxyl radical, which can damage DNA, lipids and 
biomolecules. 
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 High activities of two MAO-A and MAO-B which function to degrade   
dopamine into products that include hydrogen peroxide. 
 High content of Melanin is one of the factor contributes to oxidative stress. 
 Low GSH level in SN compared to other brain regions.(28) 
 
An imbalance between the production and elimination of reactive oxygen species 
could contribute to the pathogenesis of Parkinson’s disease and other 
neurodegenerative disorders. Metabolism of DA leads to the formation of several 
cytotoxic molecules, including superoxide anions (O2
. –), dopamine–quinone species 
(SQ·) and hydroxyl radicals (OH·). In PD, however, an abnormal increase in the 
production of reactive oxygen species might tilt the balance between production and 
elimination, leading to enhanced oxidative stress. DOPAC,3,4-dihydroxyphenylacetic 
acid MAO, monoamine oxidase. 
 
DA+O2+H2O   DOPAC+NH3+H2O2 
DA+O2  SQ
. +O2+2H+ 
DA+O2
.-+2H+    SQ. + H2O2 
H2O2+2GSH   GSSG+2H2O 
H2O2+Fe2+  OH
. +OH-+ Fe3+ 
 
Oxidative process is intimately linked to other components of the degenerative 
process such as 
 Mitochondrial dysfunction 
 Excitotoxicity 
 Nitric oxide toxicity 
 Inflammation 
 
 
 
 
 
MAO
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Mitochondrial dysfunction: 
Mitochondria are central to the generation of reactive oxygen and nitrogen 
species and integration of pro and anti-apoptotic signals in the cell.(29) It also acts as 
caspacious sink for Calcium homeostasis. The brain utilizes oxidative 
phosphorylation for generating ATP, which occurs in the inner mitochondrial 
membrane by a series of coupled redox reactions. Complex I-IV are present in inner 
mitochondrial membrane. During phosphorylation free radicals are produced from the 
transfer of  a single electron to oxygen to generate superoxide anion. Superoxide 
anion is the proximal mitochondrial ROS mainly produced in the mitochondrial 
matrix, where it is rapidly converted to hydrogen peroxide catalyzed by Mn -SOD. In 
the presence of metal ions such as Fe2+, hydrogen peroxide can be converted to the 
highly reactive hydroxyl radical (Fenton reaction). Complex I of the mitochondrial 
membrane is the main site of free radical production. The conditions favoured ROS 
production at complex I (30) 
 Low ATP production and a reduced ubiquinone pool. 
 High NADH/NAD+ ratio in the matrix. 
 
 
 
 
 
 
 
 
 
 
                                                            FIG.NO:2 
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Excitotoxicity: 
Oxidative phosphorylation is utilized for producing energy in the brain. 
Impairment of oxidative phosporylation will enhance vulnerability to 
excitotoxicity.(31)Substantia nigra neurons possess NMDA receptors and there are 
glutamergic inputs from both cerebral cortex and subthalamic nucleus. Inaddition 
subthalamic neurons provide excitatory innervations to dopaminergic neurons in the 
substantia nigra pars compact a contain glutamate receptors. After activation of 
excitatory aminoacid  receptors there is an influx of calcium followed by activation of 
nitric acid synthese leads to generation of peroxynitrate. It produces excitotoxic 
damages in  substantia nigra pars compacta. 
Nitric oxide toxicity: 
Peroxynitrite appears to be an important factor in NO induced cell toxicity. 
When cells are under oxidative stress and unable to extinguish extra reactive              
oxygen species (ROS), which will accumulate in the cells, react with NO, and form 
peroxynitrite can further react with other compounds, produce more toxic peroxide 
products, cause DNA damage and activate caspase dependent and/or independent cell 
death pathways.(32) NO and peroxynitrite-mediated DNA damage and subsequent over 
activation of poly (ADP-ribose) polymerase-1 (PARP-1) are key pathways leading to 
cell death.(33) Over activation of PARP may deplete nicotinamide adenine dinucleotide 
(NAD+) and ATP, leading to a major energy deficit and cell death and also can induce 
the translocation of apoptosis-inducing factor (AIF) from the mitochondria to the 
nucleus, and AIF is the key executioner in PARP-mediated cell death.(34) 
 
FIG.NO:3 
 
                                                                                              INTRODUCTION 
 
NEUROPROTECTIVE EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA 
DIFFUSA LINN  AGAINST MPTP INDUCED NEURODEGENARATION IN RATS 13
Inflammation: 
 
                                                               FIG.NO:4 
Putative deleterious role of neuroinflammatory processes in Parkinson’s disease 
(PD): 
Proinflammatory cytokines, including IL-1β, TNF-α and IFN-γ, induce CD23 
expression in glial cells whose engagement (by a ligand as yet to be identified) 
triggers iNOS expression and NO release. NO may amplify the production of 
cytokines within the glial cells but also diffuse to neighboring dopaminergic neurons. 
Of note, it is still debated whether infiltrated T lymphocytes could be the cellular 
source of IFN-γ in PD brain. The pathway shown in dopaminergic neuron possible 
inflammatory-associated cytotoxic mechanisms in dopaminergic neurons. NO 
produced by activated glial cells can react with superoxide (O2–) to form peroxynitrite 
(ONOO-), which can damage proteins and other cell constituents. NO also may 
contribute to oxidative stress by releasing iron from ferritin. Alternatively, cytokines 
may activate receptors (e.g. TNFR1) coupled to death signaling pathways. These 
pathways may involve activation of caspases and/or an oxidant-mediated apoptogenic 
mechanism through the release of ceramide and the activation of the transcription 
factor NFκB.(35) 
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Glutathione depletion: 
Glutathione is a potent molecular antioxidant and an essential cofactor for the 
glutathione peroxidase family of antioxidant enzymes. Its depletion contribute to 
neurodegenerative disorders. GSH depletion could arise due to genetic propensity, 
poor diet, pharmaceutical treatment (use of acetaminophen) and function of ageing. 
The reduction in GSH may impair H2O2 clearance and promote OH formation, 
particularly in the presence of increased iron. At the same time significant increase            
in the level of γ-glutamyltranspeptidase (γ-GTT-the enzyme responsible for 
translocation of glutathione  precursors and metabolism of oxidized form of 
glutathione)(36) which  recruit glutathione precursors into cells to replenish diminished 
levels of  GSH.(37) 
 
 
 
 
 
 
 
 
                                                            FIG.NO:5 
Nutritional deficiency: 
The brain uses the same nutrients that other organs use. Therefore all nutrient 
classes are useful to Parkinson’s disease. Certain individual aminoacids are precursor 
to brain neurotransmitters and significantly ameliorate symptoms when given as 
dietary supplements. L-methionine is an essential aminoacid which may benefit in 
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Parkinson’s disease. A number of B-vitamins, Vitamin C and E may also benefit in 
Parkinson’s disease.(38) 
Metals: 
Metals such as iron can promote OH formation and catalyze the transformation of -
synuclein to aggregates. Elevated level of iron present in PD substantia nigra. 
O2 + Fe2+ O2– + Fe3+ 
H2O2 + Fe2+ OH. + OH– + Fe3+ 
CLINICAL FEATURES: 
Prototypical features of Parkinson’s disease include (39) 
a. Bradykinesia 
b. Tremor 
c. Rigidity 
d. Postural instability 
It includes various motor symptoms and non motor symptoms. 
Motor symptoms: 
 Dysarthria 
 Dysphagia 
 Hypomimia 
 Hypophonia 
 Micrographia 
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Non motor symptoms 
Autonomic dysfunction 
 Hypotension 
 Bowel &bladder dysfunction 
Sensory disturbances 
 Pain 
 Paresthesia 
Mental status changes 
 Confusional state 
 Dementia 
 Psychosis 
 Sleep disturbances 
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NEUROTRANSMITTER AND RECEPTORS RELATED TO 
PARKINSON’S DISEASE 
Dopamine: 
It is a prototypical slow neurotransmitter that plays significant role in a variety of not 
only motor functions but also cognitive, motivational, and neuroendocrine.(40) 
 
Distribution of dopamine 
The distribution of the dopamine in the brain is more restricted. It is abundant 
in the   Corpus striatum, a part of the extrapyramidal system concerned with the      
co-ordination of the movement and high concentration occurs in certain parts of the 
limbic system and hypothalamus. 
 
Synthesis and metabolism 
Dopamine, a catecholamine is synthesized in the terminals of dopaminergic 
neurons from tyrosine and transported for storage in the synaptic vesicle until 
stimulation to release into synaptic cleft. Dopamine activity is terminated by reuptake 
into presynaptic neurons by a transporter called Dopamine transporter. Catabolic 
pathways involve monoamine oxidase or Catachol - O – methyl transferase.41The 
main products are Dihydroxyphenylacetic acid and Homovanillic acid. The brain 
content of Homovanillic acid is an index of dopamine turnover. 
 
                                                  FIG.NO:6 
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DOPAMINERGIC PATHWAYS IN CNS AND ITS FUNCTIONS 
Dopaminergic neurons projects from the pars compacta of the substantia nigra to the 
striatum via nigrostriatal pathways. 
 
                                                               FIG.NO:7 
There are three dopaminergic pathways 
1. Nigrostriatal pathway, involved in motor control. 
2. Mesolimbic/mesocortical pathways, running from group of cells in the 
midbrain to the part of the limbic system especially the nucleus accumbens, 
and amygdaloid nucleus and to the frontal cortex. 
3. Tuberohypophyseal system is a group of short neurons projecting from ventral 
hypothalamus to the median eminence and pituitary, the secretion of which 
regulate. 
Dopamine receptors 
On the basis of biochemical, pharmacological and physiological criteria, DA receptors 
have been classified into two groups, termed D1 and D2.(42) Genes encoding members 
of the DA receptor family are part of a larger superfamily of genes comprising the G 
protein-coupled superfamily receptors (GPCRs).(43) D1 family consists of D1 and D5 
while the D2 family which is more important in CNS function consists of D2, D3, D4. 
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Distribution: 
Dopamine receptors are expressed in the brain in distinct but overlapping areas 
D1 - is most abundant and widespread in areas receiving dopaminergic 
Innervations. (namely the striatum, limbic system, thalamus and 
hypothalamus). 
D2 -  occurs in the striatum, Substantia nigra pars compacta, pituitary gland. 
D 3  -  occurs in olfactory tubercle, nucleus accumbens and hypothalamus. 
D4  -  Distributes mainly in the central cortex, Medulla and Midbrain. 
D5       -           Distributes mainly in hypothalamus and striatum. 
D1 and D2 are linked to activation and inhibition of adenyl cyclase 
activity. 
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PATHOPHYSIOLOGY OF PARKINSON’S DISEASE 
The basal ganglia are located in the basal telencephalon and consist of five 
interconnected nuclei: the caudate nucleus, putamen, globus pallidus, substantia nigra 
and subthalamic nucleus. It has specific patterns of activation in the initiation, 
sequency and modulating of motor activity. 
Functional organization of Basal ganglia: 
 
The striatum, the main input nucleus of the circuit transmits the flow of 
information received from the cortex to the basal ganglia output nuclei, substantia 
nigra pars reticulata and medial globus pallidus, via a direct and an indirect pathway. 
The two pathways originate from different subsets of striatal neurons viz direct and an 
indirect pathway. In the direct pathway, striatal GABA ergic neurons, containing 
dynorphin as a co-transmitter and expressing D1 dopamine receptors, project mono-
synaptically to the substantia nigra pars reticulata and medial globus pallidus. In the 
indirect pathway, the striatal output reaches the target nuclei via a more complicated 
route. In  fact different subset of GABAergic neurons containing enkephaline and 
expressing D2 receptors project to the lateral globus pallidus, which sends GABAergic 
projections to the subthalamic nucleus. The subthalamic nucleus, in turn, sends its 
glutamatergic efferents to the output nuclei and to the lateral globus pallidus. From 
the output nuclei, inhibitory, GABAergic projections reach the ventral lateral and 
ventral anterior nuclei of the motor thalamus. Thalamic nuclei then send 
glutamatergic projections to the motor cortex, thus closing the loop. 
 
The activation of the direct or the indirect pathway leads to opposite changes 
in the net output of the basal ganglia circuitry. In fact, activation of the striatal 
GABAergic neurons that give rise to the direct pathway causes inhibition of GABA-
ergic neurons of the output nuclei. This leads to disinhibition of thalamic nuclei, 
which are under the inhibitory control of the output nuclei projections.Conversely, 
activation of the striatal neurons that project to the lateral globus pallidus, in the 
indirect pathway, causes inhibition of the lateral globus pallidus and subsequent 
disinhibition of the subthalamic nucleus. The activation of the subthalamic nucleus 
which is glutamatergic increases the activity of the output nuclei. Consequently, their 
inhibitory control over the motor thalamus results enhanced.(44) 
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Neurochemical changes involved in Parkinson’s disease 
The neurodegenerative process of PD causes a functional re-arrangement of 
the basal ganglia circuitry. The dopaminergic denervation of the striatum triggers a 
cascade of events that leads, ultimately, to the increased activity of basal ganglia 
output nuclei. Enhanced activity of the output nuclei would be the result of enhanced 
glutamatergic drive from the subthalamic nucleus. The model also predicts that the 
enhanced activity of the output nuclei results in an increased inhibitory control over 
the motor thalamus and subsequent reduction of the thalamic glutamatergic output to 
the motor cortex. These changes are thought to represent the neural substrate for 
parkinsonian motor symptoms.(45,46) 
 
 
                                                         FIG.NO:8 
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NEUROPATHOLOGY OF PARKINSON’S DISEASE 
The pathological hallmarks of Parkinson’s disease are round eosinophilic 
intracytoplasmic proteinacious inclusions termed Lewy bodies (LBs) and dystrophic 
neuritis present in surviving neurons. In PD nirostriatal pathway degenerates.As a 
result marked loss of dopaminergic neurons that project to the putamen and much 
more loss of those project to caudate (thin red line).19 
 
 
                                              FIG.NO:9 
The familial PD linked genes, responsible for pathogenesis are α-synuclein, 
Ubiquitin C-terminal hydrolase L1 (UCHL1), Parkin, PINK I and a newly identified 
gene known as DJ-1. Mutations in α-synuclein and UCHL1 are linked to autosomal 
dominant familial PD, while mutations in parkin and DJ-1cause autosomal recessive 
PD (ARPD). 
 
α-SYNUCLEIN IN PARKINSON’S DISEASE 
α-synuclein is a 140 aminoacid protein consists of a N –terminal amphipatic 
region containing six imperfect repeats (with a  KTKEGV consensus motif), a 
hydrophobic central region containing non-amyloid β component domain and an 
acidic terminal region. It is intrinsically unstructured or native unfolded protein which 
has significant plasticity. It is highly expressed throughout the mammalian brain and 
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is enriched in presynaptic nerve terminals, where it can associate with membranes and 
vesicular structures. α-synuclein is considered to play a central role in the 
pathophysiology of PD. Two missense mutations in A30P and A53T in alpha 
synuclein display an increased propensity to self-aggregate to form oligomeric 
species. The A53Tand A30P mutations both share the capacity to promote the 
oligomerization, but not fibrillization, of α-synuclein.22Catecholamines, particularly 
dopamine, can react with α-synuclein to form covalent adducts that slow conversion 
of protofibrils to fibrils.Fibrillar forms of the α-synuclein protein as a major structural 
component of LBs in PD.(47) 
 
 
 
Alpha synuclein fibrillogenesis 
 
                                                 FIG.NO:10 
 
PARKIN: 
 
It encoded by a PARK2 gene. The parkin gene encodes a 465-amino-
acidprotein with a modular structure that contains an N-terminal ubiquitin-like (UBL) 
domain, a central linker region, and a C-terminal RING domain comprising two 
RING finger motifs separated by in-between-RING (IBR) domain parkin can function 
as an E3 ubiquitin protein ligase.23 E3 ligases are an important part of the cellular 
machinery that covalently tags target proteins with ubiquitin. Ubiquitination of 
proteins results from the successive actions of ubiquitin-activating (E1), conjugating 
(E2), and ligase (E3) enzymes resulting in the formation of a poly-ubiquitin chain 
containing four or more ubiquitin molecules. Such poly-ubiquitinated proteins are 
specifically recognized by the 26S proteasome and are subsequently targeted for 
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degradation. Mutation in the parkin gene results in the failure of ubiquitin 
proteosomal system for degradation of proteins which finally leads to cell death. 
 
 
.  
                                                   FIG.NO:11 
 
THE UBIQUITIN-PROTEASOME SYSTEM: 
Ubiquitin (Ub) monomers are activated by the Ub-activating enzyme (E1) and 
are then transferred to a Ub-conjugating enzyme (E2). Normal or abnormal target 
proteins are recognized by a Ub protein ligase (E3), such as parkin, which mediates 
the transfer of Ub from the E2 enzyme to the target protein. The sequential covalent 
attachment of Ub monomers to a lysine (K) acceptor residue of the previous Ub 
results in the formation of a poly-Ub chain. Poly-Ub chains linked through K29 or 
K48 signal the target protein for degradation through the 26S proteasome in an ATP-
dependent manner, resulting in the generation of small peptide fragments. The 
resulting poly-Ub chains are recycled to free Ub monomers by deubiquitinating 
(DUB) enzymes, such as UCH-L1, for subsequent rounds of ubiquitination. The 
addition of Ub also has other diverse roles. Normal protein can be singly or multiply 
mono-ubiquitinated, or poly-ubiquitinated with K63-linked chains, which lead to non 
proteasomal functions that include DNA repair, endocytosis, protein trafficking, and 
transcription.(48) 
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UBIQUITIN C- TERMINAL HYDROLASE L1 (UCHL1) 
UCHL1 belongs to the family of deubiquitinating enzyme, abundantly 
expressed in the brain (about 1% of total brain protein) and its expression is highly 
specific to neurons and to cells of endocrine lineage.The function of UCHL1 is that 
hydrolysis of small C-terminal adducts-ubiquitins which is important in proper 
functioning of Ubiquitin-Proteosome system. 
 
Mutation of UCHL-1 leads to aberrations in proteolytic pathways and 
aggregation of proteins in Lewy bodies.19 
 
 
PINK1: 
PINK1 is a 581-amino-acid protein that contains a mitochondrial targeting 
sequence at its N-terminus and a highly conserved protein kinase domain. PINK1is 
considered to be a mitochondrial protein kinase, phosphorylates mitochondrial 
proteins, in response to cellular stress, to prevent mitochondrial dysfunction.(49) 
Mutation in PINK1 causes the loss of the putative kinase activity of PINK1 that 
affects mitochondrial function. 
 
 
DJ1 
Mutations in DJ-1cause autosomal recessive PD (ARPD). DJ-1 is more 
relevant to PD. Pathogenesis is its putative function as an antioxidant protein. 
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COMMON PATHWAYS UNDERLYING PD PATHOGENESIS: 
 
                                                      FIG.NO:12 
 
Mutations in five genes encoding α-synuclein, parkin, UCHL1, PINK1, and 
DJ-1 are associated with familial forms of PD through pathogenic pathways that may 
commonly lead to deficits in mitochondrial and UPS function. PINK1, parkin, and 
DJ-1 may play a role in normal mitochondrial function, whereas parkin, UCH-L1, and 
DJ-1 may be involved in normal UPS function. α-synuclein fibrillization and 
aggregation is promoted by pathogenic mutations, oxidative stress, and oxidation of 
cytosolic dopamine (DA), leading to impaired UPS function and possibly 
mitochondrial damage. α-synuclein may normally be degraded by the UPS. Some 
environmental toxins and pesticides can inhibit complex-I and lead to mitochondrial 
dysfunction, whereas alterations in mitochondrial DNA (mtDNA) may influence 
mitochondrial function. Impaired mitochondrial function leads to oxidative stress, 
deficits in ATP synthesis, and α-synuclein aggregation, which may contribute to UPS 
dysfunction. Oxidative and nitrosative stress may also influence the antioxidant 
function of DJ-1, can impair parkin function through S-nitrosylation, and may 
promote dopamine oxidation. Excess dopamine metabolism may further promote 
oxidative stress. Mitochondrial and UPS dysfunction, oxidative stress, and α-
synuclein aggregation ultimately contribute to the demise of DA neurons in PD.Red 
lines indicate inhibitory effects, green arrows depict defined relationships between 
components or systems, and blue dashed arrows indicate proposed or putative 
relationships.(50) 
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STAGES OF PARKINSON’S DISEASE 
Stages of Parkinson’s disease are of five.(51) 
Stage 1: 
 Signs  and symptoms on one side only 
 Symptoms  mild 
 Symptoms inconvenient but not disable 
 Usually presents with tremor  of one limb 
 The noticed changes in posture, locomotion and facial expression 
Stage 2: 
 Symptoms are bilateral 
 Minimal disability 
 Posture and gait affected 
Stage 3: 
 Significant slowing of body movement 
 Early impairment of equilibrium on walking  or standing 
 Generalised dysfunction that is moderately severe 
Stage 4: 
 Severe symptoms 
 Can still walk to a limited  extent 
 Rigidity and bradykinesia 
 No longer able to live alone 
 Tremor may be less than early stage 
Stage 5: 
 Cachetic stage 
 Invalidism complete 
 Cannot stand or walk 
 Require constant nursing care 
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DIAGNOSIS OF PARKINSON’S DISEASE 
There is no single cause method to make a positive diagnosis of Parkinson’s 
disease the following are somewhat help to diagnose Parkinson’s disease. 
1. Neuroimaging 
2. Olfactory system testing 
3. Autonomic system testing 
 
 
NEUROIMAGING 
In this Single Photon emission Tomography is used along with radiolabelled 
compound. The compound will bind on to dopamine receptors and can be viewed 
using SPECT.This method allows the measurement of amount of dopamine releasing 
neurons. 
 
 
OLFACTORY TESTING 
In this the patient has to smell a variety of odours and then making a choice 
from a variety of possible answers for each one. 
 
 
AUTONOMIC SYSTEM TESTING 
Testing involves examining breathing, heart rate, reflexes and 
thermoregulation. 
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TREATMENTS 
There is no single, optimal treatment for disease.Currently available therapies either 
boosts the levels of dopamine in brain or mimic the effects of dopamine.(52,53) 
Levodopa: 
Levodopa has been the mainstay of pharmacological treatment for Parkinson’s 
disease. It is   the  metabolic  precursor  of dopamine, crosses  the blood  brain  barrier   
by   a  large  neutral  amino acid  transporter and is  capable  of  reaching  the  striatal  
tissue  where  it is  decarboxylated  to  dopamine.Taken alone it causes nausea and 
undergoes rapid metabolism by peripheral decarboxylase. To overcome this limitation 
it should be given along with dopa decarboxylase inhibitor Carbidopa. Levodopa 
decreases the rigidity, tremors and other symptoms of Parkinson’s disease. The daily 
dose of L.dopa depending on symptoms and severity of side effects. L. dopa and 
carbidopa given as combined tablets (sinimet). On long term therapy causes motor 
fluctuations and dyskinesia occur in most patients. 
 
Mono Amine Oxidase B   inhibitors: 
Eg: Selegiline, Rasagline. 
Selegiline, the agent for symptomatic treatment  of  parkinson’s  disease   
prolongs  the  half  life  of  endogenously  produced  dopamine  by   retarding   the    
breakdown of dopamine in the striatum which benefit the patients of   parkinsonism. 
Adverse effects such as Involuntary movements, postural hypotension, nausea,  
confusion  and  psychosis. 
 
Rasagiline is  restricted   analog  of   selegiline   and  is  a  newly  approved   
compound  for  treatment   of   PD.It  has  MAO- B  inhibitory  activity. 
 
Muscarinic receptor antagonists: 
These are  useful  in the  management  of  mild to  moderate   symptoms  of  
the  drug induces parkinsonism. Trihexphenidyl or Benztropine are specially against 
tumor. In addition to it also reduces bradykinesia. Dryness of mouth, hallucination, 
confusion, agitation. Increased sensitive to dementia are major limitations. 
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Catachol - O - Methyl transferase inhibitors: 
Eg: Tolcaptone, entacapone. 
These are act by inhibiting catachol- o-methyl transferase and   reduce   
central, peripheral metabolic degradation of L dopa. Hypotension, abdominal pain, 
diarrhoea, urinary discolouration, dyskinesia are major side effects. 
 
Dopamine releasers: 
Eg: Amantadine 
It   inhibits   the  activity   of    NMDA   receptors    and   it   promotes   the   
release, prevents  reuptake  or have  an  influence the  synthesis  of  dopamine                        
It  produces   cardiovascular  disorders  and  also  induces   seizures. It   also   
produces   restlessness, depression, confusion and hallucinations. 
Ergot derivatives - Bromocryptine, Pergolide, Lisuride, Cabergoline. 
Non Ergot derivatives- Ropinrole, Pramiprexole, Apomorphine, Pirebedil.  Both act by 
specific D2 alone. They may be used alone to delay the need for Levodopa. 
Novel therapeutic approaches: 
GDNF: 
It has ability to protect degenerating dopamine neurons in PD as well as promote 
regeneration of nigrostiatal dopamine system.But there is a very little evidence to 
support its widespread use. 
The treatments under investigation: 
Eg: Adenosine antagonists, alpha 2 adrenergic receptor antagonists. 
LIMITATIONS OF CURRENT THERAPIES: 
At highly progressed condoned of Parkinson’s disease; the therapy may be 
minimal of use.Hence these agents are adequately soluble when administer via this 
route so, various techniques designed to improve the effectiveness of transversal drug 
delivery and developing more soluble and effective drugs. 
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NEWLY RESEARCHED NEUROPROTECTIVE AGENTS 
Antioxidants play an important role in neuroprotective therapy.Antioxidant 
such as Tocopherol and Tocotrienols, Ascorbate, Vitamin D and vitamin E and 
minerals such as Zinc and selenium.(54,55) 
Curcumin 
 It has free radical scavenging activity. 
 Potent inhibitor of peroxy nitrate and lipid peroxidation by enhancing the 
production of glutathione and protects neurons from degeneration. 
Α-Lipoic acid 
 Alpha lipoic acid and its reduced form, dihydrolipoic acid (DHLA) also 
enhance cellular glutathione production. 
 It also neutralise the   hydroxyl radical, singlet oxygen hypochlorite, nitric 
oxide radicals and hydrogen peroxide. 
Melatonin 
 It is a powerful neuroprotectant. 
 It acts as a free radical scavenger which reacts with hydroxyl radical, hydrogen 
peroxide, singlet oxygen, peroxynitrite, nitric oxide and hypochlorous acid. 
 It stimulates the production of antioxidant enzymes such as superoxide 
dismutase, glutathione peroxidase and glutathione reductase. 
Coenzyme Q-10 
 It can act by regenerating Vitamin-E which inturn stimulate α-Lipoic acid 
which can increase the level of Ubequinol, an agent for protecting oxidative 
stress. 
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Vitamin A, C AND E 
 Lipid peroxidation  is increased in the substantia nigra of patients with 
Parkinson’s disease, suggesting that excess of free radicals contributes to 
nigral striatal neurodegeneration. 
 Vitamin A, C&E are all proven antioxidants capable of preventing lipid 
peroxidation by acting as free radical scavenger. 
OTHER AGENTS 
 Flavanoid polyphenols such as epigallocatechin 3-gallate from green tea and 
quercetin from apples. 
 Non flavanoid polyphenols such as resverastrol from grapes. 
 Phenolic acids or phenolic diterpenes such as rosmarinic acid or carnosic acid 
from rosemary. 
 Organosulphur compounds such as isothiocyanate,L-sulphoraphane from 
broccoli,and thiosulphonate allicin from garlic. 
 Mucuna pruriens contain levodopa.But its clinical efficacy cannot be proven.It 
is under double blind trial. 
 Ghrelin: Its function is to preserve the production and release of dopamine by 
substantia nigra. 
Synthetic drugs 
Caffeine, Cannabis, L- Carnitine. 
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NON PHARMACOLOGICAL TREATMENT UNDER 
INVESTIGATION 
 
 New drug delivery system for Parkinson’s disease are increasingly more 
focused on site specific delivery of Pharmaceuticals. It includes the delivery of 
various newly researched drugs, genes, viruses and various peptides.50 
 
Cell transplantation 
 Transplantation of dopamine producing neurons to replace these degenerated 
neurons during the pathogenesis of Parkinson’s disease is a promising 
approach to treatment. 
 Hence it is the only advancement that has been shown the capacity to allow 
patients to achieve full restoration of their functional capacity. 
 Grafts have shown minimal immunological rejection in recepients and in most 
successful trials have allowed patients to withdraw from Levodopa therapy. 
 
LIMITATIONS 
 Poor rate of graft cell survival was reported. 
 
Gene therapy 
 Neurologix’s gene therapy is the only one gene strategy currently in 
development which by passes the dopamine system. 
 In Parkinson’s disease, patient’s loss dopamine producing brain cells, resulting 
in substantial reduction in the activity and amount of GABA, the major 
inhibitory neurotransmitter in the brain, which contributes to abnormal 
increase in the activity of the STN of the brain.The gene responsible for 
GABA, is called glutamic acid decarboxylase. 
 This involves restoring GABA and improving the patient’s motor control. 
 
LIMITATIONS 
 However this technology remains in the experimental stages of development  
and in 2nd phase of clinical trials 
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Surgical methods 
 Pharmacological therapy for Parkinson’s become inadequate over long 
term use. 
 Surgical interventions for Parkinson’s disease have been shown to be 
beneficial for refractory symptoms. 
 Thalamotomy and thalamic stimulations are considered as safe and 
effective procedures to treat tumors. 
 Pallidotomy and pallidol stimulation primarily reduces dyskinesia. 
 Currently Deep brain stimulation is the intervention of choice because 
this is more safer than other available techniques. 
 
Table. 2:- SURGICAL INTERVENTIONS OF PARKINSON’S DISEASE. 
Surgical intervention Description of Procedure 
Pallidotomy 
 
Thalamotomy 
 
Thalamic stimulation 
 
 
 
Deep brain 
stimulation 
It involves the use of an electric probe to destroy the small porting 
of the brain that is over active and thought to cause symptoms  of 
PD. 
 
It involves the removal of the thalamus in the brain .The thalamus is 
responsible for involuntary movements. It is rarely performed and 
only effective in providing relief from tumors. 
Involves the insertion of an electrode wire into thalamus, the other 
end of which is connected to pulse generator under the skin in the 
thorax. The advantage of this procedure is that it can produce the 
benefit of thalamotomy without causing incision of the skin and 
demonstrated efficiency in the management of tremor in PD. 
It is an alternative procedure used to destroy  small regions of  the 
brain .A thin electrode implanted into the brain prevents 
transmission of impulses for involuntary movements.50 
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ANIMAL MODELS FOR PARKINSON’S DISEASE 
 
1. Acute Pharmacologic models(56) 
Reserpine induced Parkinsonism 
Haloperidol induced Parkinsonism 
Ferric chloride induced Parkinsonism 
Cholinomimetics induced Parkinsonism 
 
2. Models exhibiting destruction of Dopaminergic nigrostriatal pathway 
Surgical induction 
6-OHDA model with partial lesion 
6-OHDA model with full lesion 
 
3. Pesticide induced model 
Rotenone induced model 
Paraquat induced model 
 
4. Animal models based on hallmarks of PD 
Proteosomal inhibitor models 
Glial activation models 
 
MPTP MODEL OF PARKINSON’S DISEASE 
 MPTP model of Parkinsonism is the most clinically relevant of all available 
models which mimics the clinical features of Parkinson’s disease and also used for 
antiparkinsonism medications. 
 
Mechanism of MPTP 
MPTP, a neurotoxin that produces Parkinsonian syndrome in both humans and 
experimental animals.(57) 
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It is a highly lipophilic molecule crosses the blood brain barrier in a matter of 
seconds of systemic injection. 
It is taken up into astrocytes where it is metabolized to MPP+ by monoamine oxidase 
–B. 
MPP+ extruded from the astrocytes is taken up into mitochondria of 
dopaminergic neurons by DAT where it disrupts the oxidative phosphorylaton by 
inhibiting complex-1 site of mitochondrial electron transport chain. 
This leads to impairment of ATP production, elevation in intracellular calcium levels 
and upregulation of TNF α, ILβ and nitric oxide synthase. 
Upregulation of nitric oxide synthase increases the presence of nitric oxide.In 
the cytosol of dopamine neurons, nitric oxide reacts with superoxide dismutase to 
produce strong oxidant peroxynitrate which can damage cellular proteins, lipids and 
DNA, leads to neuronal damage. 
Specific degeneration 
MPTP treatment can induce the m-RNA expression of nNOS and guanyl 
cyclase beta subunit(GCβ1) which leads to elevation in their protein levels and 
activated within the striatum and substantia nigra. These effects are accompanied by 
marked enhancement of C-GMP formation.7-Nitroindazole is used to decrease MPTP 
induced elevation in C-GMP levels.(58) 
Poly (ADP-Ribose) polymerase is also involved in DNA plasticity such as 
repair of DNA damage, gene expression and carcinogenesis. Extensive PARP 
activation can promote cell death by energy depletion. Toxic effect of MPTP is 
mediated through excessive production of PARP. PARP inhibitors such as Benzamide 
are known to prevent MPTP induced neurotoxicity. 
Neuroprotective factors produced after intoxication with MPTP prevent 
dopaminergic neurons from neuronal death by modulation of oxidative stress and 
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inflammation. GDNF is a potent neurotropic factor that has restorative effects in a 
wide variety of rodent and primate models of PD. 
 
 
 
 
 
                                                            FIG.NO:13 
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OXIDATIVE STRESS AND EXCITOTOXICITY IN 
PARKINSON’S DISEASE 
Oxidative stress is a major player in the pathology of Parkinson’s disease. 
Oxidative stress damages nucleic acids, proteins and lipids and potentially opens the 
mitochondrial permeability transition pore which inturn can further stimulate ROS 
production, worsen energy failure and release proapoptotic factors such as cyochrome 
into the cytoplasm. Generation of high levels of ROS and downregulation of 
antioxidant mechanisms results in neuronal death. 
The brain utilizes mitochondrial phosphorylation for energy production. Free 
radicals are side products of this process.The most common cellular free radicals are 
superoxide radical, peroxynitrate and hydroxyl radicals. When antioxidant system 
becomes overwhelmed by these free radicals oxidative damage and cell death can 
occur. Problems occur when ROS exceeds their elimination by the antioxidant 
protection system. The unbalance between cellular production of ROS and inability of 
cells to defend against these effects is called oxidative stress. 
NO production increases in neurodegenerative disease as a consequence of 
oxidative stress. NO is activated by the release of glutamate combined with inhibition 
of glutamate removal which leads to NMDA receptor over activation and excess 
calcium influx.Excess of calcium influx is one of the cause of excitotoxicity and 
induce neuronal damage.(59) 
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                                                    LITERATURE REVIEW 
1. Nagaraja Halaegrahara, et al.,(2010) investigated  the neuroprotective effect of Centella 
asiatica  extract against MPTP induced neurotoxicity in aged Sprague-dawley rats.For 
this study  rats were divided into four groups such as control, Centella asiatica alone,  
MPTP alone (20mg/kg for 21 days) and MPTP with Centella asiatica (300mg/kg for 21 
days).They demonstrated that datas from the  evaluation of hippocampus homogenate 
shown MPTP  challenged rats elicited a significant increase in Lipid peroxides (LPO) 
(P<0.01), PCC (P<0.01) and xanthine oxidase when compared with control rats. 
Furthermore, there  is a significant decrease in total antioxidants (TA) (P<0.001), SOD 
(P<0.001), glutathione peroxidase (P<0.01) and catalase (P<0.001) level with MPTP 
treatment. These findings suggested that supplementation of CAE could reduce LPO and 
PCC significantly increased total antioxidant  and antioxidant level in striatum and 
hippocampus. So CAE is effective in protecting the brain against neurodegenerative 
disorders  such as Parkinsonism. (60) 
 
2. M.Mohanasundari, et al.,(2007) evaluated the neuroprotective effect of Hypericum 
perforatum extract on the reaction of astrocytes in mice brain treated with an intraperitoneal 
injection of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (20 mg/kg with 2 hr 
intervals). They suggested that treatment with Hypericum perforatum extract (HPE) resulted 
in an inhibition of monoamine oxidase-B (MAO-B) activity and reduced astrocyte activation 
in striatal area induced by MPTP. These results show that HPE has neuromodulating effect 
against MPTP induced Parkinson’s disease in mice.(61) 
 
3. Li-Xing Liu, et al.,(2008) investigated the neuroprotective effect of Genistein, an isoflavone 
naturally found in soya products on dopaminergic neurons in ovariectomized 1- methyl 4- 
phenyl 1,2,3,6 tetrahydropyridine induced PD model mice. They suggested that pretreatment 
with genistein significantly restore the level of dopamine, DOPAC and homovanillic acid 
and MPTP-induced down regulation of TH, dopamine transporter (DAT) and Bcl-2 mRNA 
expression in the midbrain in MPTP induced mice. Furthermore, MPTP-challenged with 
genistein group shown reduced neurotoxicity, with tyrosine hydroxylase-immunoreactive 
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(TH-IR) neurons in the substantia nigra pars compacta (SNpc) affected to a significantly 
lesser extent as compared to the MPTP treated control. These findings evidenced that 
genistein has neuroprotective effects on dopaminergic neurons in the MPTP-induced PD 
mice and this effect may be attributed to enhancing Bcl-2 gene expression.(62) 
 
4. Linjuan Sun, et al.,(2010) investigated the effect of cysteamine against 1-methyl-4-phenyl-1, 
2, 3, 6-tetrahydropyridine (MPTP)-induced toxicity in the dopaminergic neurons in a mouse 
model for Parkinson's disease (PD). They suggested that pretreatment with low dose 
cysteamine (20 mg/kg/day) significantly reduce the loss of dopaminergic (DA) neurons and 
reduction in striatal DA concentrations and also reduce the increased production of pro-
oxidants, such as reactive oxygen species (ROS) and malonidialdehyde and increased GSH 
level. In addition, the inhibited secretion of the brain derived neurotrophic factor (BDNF) by 
neurons derived from substantia nigra pars compacta(SNpc) of MPTP-treated mice was 
significantly restored by cysteamine administration. These results demonstrated that 
cysteamine at low dose confers potent neuroprotection against MPTP-induced toxicity of 
dopaminergic neurons, and may become a potential therapeutic strategy for PD.(63) 
 
5. Angela B. Reksidler, et al.,(2007) investigated the effects of the selective cyclooxygenase-2 
(COX-2) inhibitor parecoxib (Bextra™) in the prevention of motor and cognitive 
impairments observed in rats after an intranigral infusion of 1-methyl-4-phenyl-1, 2, 3, 6-
tetrahydropyridine (MPTP), a model of the early phase of Parkinson's disease. They 
suggested that treatment with parecoxib (10 mg/kg) administered prior to the surgery and 
daily (2 mg/kg) for the subsequent 21 days, prevented the MPTP-treated rats from presenting 
decreased locomotor and exploratory behavior, increased immobility, and impairment while 
performing the cured version of the Morris water maze. Furthermore, parecoxib treatment 
also significantly prevented the reduction of tyrosine hydroxylase protein expression in the 
substantia nigra (7, 14 and 21 days after surgery), and in the striatum (14 and 21 days after 
surgery) as immune detected by western blotting. These results strongly suggested that 
parecoxib exerts a neuroprotective effect on motor, tyrosine hydroxylase expression, and 
cognitive functions as it prevents their impairments within the confines of this animal model 
of the early phase of Parkinson's disease.(64) 
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6. Qing Zhao, et al.,(2010) investigated the effects of Echinacoside (ECH), a monomer 
extracted from herbs, on rescuing dopaminergic function in 1-methyl-4-phenyl-1, 2, 3, 6-
tetrahydropyridine (MPTP)-lesioned mice. We found that oral administration of ECH (30 
mg/kg/day for 14 days) to MPTP-treated mice, commencing after impairment of the 
nigrostriatal system, suppressed the reduction of nigral dopaminergic neurons, striatal fibers, 
dopamine and dopamine transporter to 134.24%, 203.17%, 147.25% and 154.72% of MPTP-
lesioned animals respectively(p<0.05). There was a relative elevation in expression of GDNF 
and BDNF mRNA (2.94 and3.75-fold) and protein (184.34% and 185.93%) in ECH treated 
mice compared with vehicle treated MPTP lesioned mice (p<0.05). In addition, the apoptosis 
cells and Bax/Bcl-2 ratio of m RNA and protein in MPTP-lesioned mice significantly 
increased, and these effects could be prevented by ECH. At the 7th and 14th days of ECH 
treatment, the gait disorder displayed obvious improvement (p<0.05). These findings 
strongly demonstrated that ECH is probably a novel, orally active, non-peptide inducer of 
NTFs and inhibitor of apoptosis, and they provide preclinical support for therapeutic 
potential of this compound in the treatment of PD.(65) 
 
7. Hua-Qing Liu, et al.,(2006) investigated, Paeoniforin attenuates neuroinflammation and 
dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease by activation of 
adenosine A1 receptor. They explained subcutaneous administration of PF (2.5mg/kg and 
5mg/kg)for 11 days could protect tyrosine hydroxylase positive  substantia nigra neurons and  
striatal nerve fibres from death and bradykinesia induced by four dose injection of 
MPTP(20mg/kg)on day 8.These findings demonstrated that PF could reduce MPTP induced 
toxicity by inhibition of neuroinflammation by activation of A1 and A2 and suggested that PF  
might be a valuable neuroprotective agent for treatment of PD.66 
 
8. Amit Gupta, et al., (2010)evaluated the neuroprotective effect of nimesulide, a preferential 
COX 2 inhibitor against 1 methyl-4-phenyl-1, 2, 3.6 tetrahydropyridine (MPTP) rat model of 
Parkinson’s disease. They evaluated three parameters such as behavioural, biochemical and 
histological parameters for this study. Behavioural evaluation demonstrated that intrastriatal 
administration of MPTP (32Μmol in 2μl) produce a significant decrease in locomotor 
activity. Biochemical investigation of striatal region revealed that MPTP  treated group  
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shown significant enhancement in oxidative stress in striatal region evidenced by increased 
lipid peroxidase levels, nitrate levels, myeloperoxidase activity along with depleted 
antioxidant pool and reduced redox (GSH/GSSG) ratio and  also produce significant 
mitochondrial complex-I inhibition and reduction in mitochondrial viability. 
Histopathological examination of MPTP treated brain sections revealed some alteration in 
histoarchitecture. Furthermore, chronic administration of nimesulide at a dose of 5mg/kg p.o 
for 12 days reversed the MPTP induced effects. These findings strongly demonstrated that 
therapeutic value of COX inhibitors in treatment of neurodegenerative disorders such as 
Parkinson’s disease.(67) 
 
9. B.Han, et al.,(2010) found out the effect of Hydroxysafflor yellow A (HSYA) on MPTP 
induced neurotoxicity in mice. They suggested that pretreatment with hydroxysafflor at a 
dose of 2,8mg/kg for a week was followed by intraperitoneal injection with MPTP (30mg/kg) 
for five consecutive days. After that the subsequent behavior, biochemical index and 
immunohistochemical manifestations in mice were determined. Behavioral testing showed 
that MPTP-treated mice exhibited motor deficits but HSYA prevented the appearance of 
motor abnormalities. HSYA treated mice at dose of 8 mg/kg attenuated the reduction of 
dopamine (DA), 3, 4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) 
and also the activity of SOD, catalase activity and GSH levels were significantly higher, 
compared to the MPTP-treated mice. These results indicated that HSYA possesses 
neuroprotective effects and is a promising anti-Parkinson’s disease drug which is worthy of 
further study.(68) 
 
10. Ying Jui Ho, et al.,(2011) evaluated the role of NMDA receptors in neuronal and behavioural 
changes in a 1 methyl -4 phenyl -1, 2, 3, 6- tetrahydropyridine disease. One day after 
intranigral infusion of MPTP causes transient disturbance in motor function which was 
evaluated by using Rotarod. MPTP lesioned rat’s causes deficit in working memory and 
anxiety like behavior in elevated plus maze test and T maze test respectively. Furthermore, 
MPTP lesioned rats failed to recognize object, disrupted the level of interleukin 2 in striatum, 
amygdala and non-prefrontal cortex were increased and cell loss in the hippocampal CA1 
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area. These effects were improved by DCS treatment. These results suggested that NMDA 
receptors play a key role in PD-related neuronal and behavioural dysfunction.(69) 
 
11. Salman khan M, et al., (2013) investigated chemotherapeutic potential of Boerhaavia 
diffusa linked from ancient time to the present with the scope in future. Furthermore a 
recent update on mechanistic approaches of B. diffusa has also been discussed. Based on 
antioxidant & antdiabetic characteristic it is hypothesized that Boerhaavia diffusa might 
exhibit antiglycating properties.(70) 
 
12. Kanjoormana Aryan Manu, et al., (2009) evaluated Immunomodulatory activities of 
punarnavine, an alkaloid from B. diffusa  using Balb/C mice. Punarnavine enhanced 
proliferation of splenocytes, thymocytes and bone marrow cells both in presence and 
absence of specific mitogens in vitro and in vivo. More over administration of Punarnavine 
significantly reduced the LPS induced elevated levels of pro inflammatory cytokines such 
as TNF-α, IL-1β and IL-6 in mice.(71) 
 
13. Mandeep kaur, et al.,(2011) investigated the methanolic extract of Boerhaavia diffusa 
roots & its different fraction including liriodendrin rich fraction for exploring the possible 
role of liriodend rinrich in its anticonvulsant activity. These finding concluded that 
observed anticonvulsant activity was due to calcium channel antagonistic action as this 
activity was retained only in liodendrin rich fraction which posse’s significant 
anticonvulsant activity of liriodendrin in BAY K-8644 induced seizures.(72) 
 
 
14. Sandhya.k, et al., (2010) had conducted a comparative study of hydro alcoholic extract 
and poly herbal formulation of Boerhaavia diffusa for their  anti stress activity using cold 
restrainst stress model. Due to cold restrain stress there was imbalance in  the level of 
biochemical parameter like glucose, triglycerides, cholesterol, SGOT, SGPT which were 
near normalized following the administration of HEBD &  PHF-09. HEBD and PHF-09 
were found to have comparable anti stress activity. (73) 
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15. Surendar. k. Pareta et al.,( 2011) found out the effects of pre treatment of aqueous extract 
of Boerhaavia diffusa root( 200-400 mg/kg /day) in repeated dose acetaminophen 
nephrotoxic rats for 14 days. Acetaminophen administration characterized by significant 
increase in Blood urea nitrogen (BUN), serum creatinine and increased level of kidney 
malondialdehyde prolein thiol, along with depletion of SOD, CAT, GPX and GSH. 
.Histopathological changes showed significant structural damage to kidney. The result 
suggest that Boerhaavia diffusa has the potential in preventing the acetaminophen induced 
Nephrotoxicity.(74) 
 
16. Ramachandran. y. L, et al.,(2010) evaluated the hepatoprotective properties of petroleum 
ether extract, Methanolic extract and isolated compound of B. diffusa & A. lanata against 
carbon tetra chloride induced hepatic damage in rats. This study reveals that different dose 
of plant extract offer significant protection of serum test and liver histology.(75) 
 
 
17. Shisode. k.s, et al., (2011) had studied that different extract of roots of Boerhaavia diffusa 
for invitro antioxidant activities & phytochemical screening. Among these there extract, 
ethanolic extract had shown better antioxidant activity & phytochemical screening revealed 
the presence of carbohydrate, saponins, proteins, flavonoids, steroids, fats & alkaloid.(76) 
 
18. Gopal. T.k, et al.,( 2010) evaluated invitro antioxidant activities of chloroform, ethanol &  
ethyl acetate fraction of B. diffusa. L which might have improved it’s hepatoprotective 
action. The extract found to have significant Nitric oxide and DPPH radical scavenging 
activity. The result suggest  that roots of Boerhaavia diffusa were found to reveal 
antioxidant potential which support the use of plant in traditional medicine.(77) 
 
19. Apurba sarker Apu. et al.,( 2012) investigated the bioactivities of crude n-hexane, ethyl 
acetate and methanolic extract of aerial parts of the Boerhaavia diffusa linn and its 
phytochemical analysis. Methanolic extracts showed higher anti oxidant, thrombolytic 
activity and less cytotoxic activity than that of n-hexane & ethyl acetate extract of 
Boerhaavia diffusa. All the extract showed significant inhibitory activity aqainst candida 
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albicans at a concentration of 1000µg/disc. These findings suggest that plant could be 
important source of medicinally important natural compound.(78) 
20. Shukla Anamika and Gupta Rakesh kumar, (2011) studied the effects of aqueous 
extract of Boerhaavia diffusa  roots and leaves on blood sugar level in Alloxan induced  
diabetic  rats. These studies conclude that aqueous extract of B. diffusa have shown 
hypoglycemic effect may be due to presence of glycosides, flavonoids, tannins and saponin 
in the extract.(79) 
 
21. Suralkas A.A et al.,(2012) investigated antihistamine activity of ethanolic extract  of 
Boerhaavia diffusa linn roots using isolated goat tracheal chain and histamine induced 
bronchoconstriction in Guinea pig Boerhaavia diffusa significantly inhibited dose 
dependent contraction of goat tracheal chain produced by histamine and also showed 
significant protection by prolonging preconvulsion dyspnoea time in guinea pigs. Thus 
Boerhaavia diffusa showed antihistaminic and bronchodilating activity against histamine 
and hence posses potential role in treatment  of asthma.(80) 
 
22. Surendran. k, et al., (2010) evaluated anti urolithiatic activity of Boerhaavia diffusa lina 
root aqueous extract and rationalize it’s use in treating renal stone. The lithogenic treatment 
causes weight loss, hyperoxalurea and impairment  of renal function. Boerhaavia diffusa 
linn causes diuresis and hasten the process of dissolving crystals and helps in mechanical 
expulsion of  stones and improve the renal function by removing the waste product and 
decrease oxalate excretion by interfering with metabolism. Results of this study indicate 
Boerhaavia diffusa linn posses antiurolithiatic that possibly mediated through diuretic and 
hypo-oxaluric effects.(81) 
 
23. Mahesh, A.R, et al., (2012) had conducted a detailed study on Boerhaavia diffusa for it’s 
medicinal importance. Various phytochemical ,pharmacological ,experimental and clinical 
investigation are done on Boerhaavia diffusa. This include evidence based over view of 
pharmacological, phytochemical properties of aerial parts & the roots of Boerhaavia 
diffusa ,which may be helpful to establish a standard natural drug for further studies.(82) 
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24. Meena, A.K, et al., (2010)  investigated the standardized and phytochemically evaluated 
aqueous and hydroalcoholic extracts of Boerhaavia diffusa. It involve pharmacognostical 
examination of morphological and microscopical characters and phytochemical 
investigation of Boerhaavia diffusa including determination of loss on drying, ash values, 
TLC and extractive values. The qualitative chemical examination revealed the presence of 
various phytoconstituents like carbohydrate, ,saponins, phenolic compound and mucilage 
in the extract.(83) 
 
25. Babita Aqrawal,et al., (2011) have investigated a review on it is phytochemical and 
pharmacological profile  Phytochemical studies had shown the presence of rich source of 
alkaloids, steroids and flavones. pharmacological research  explains hepatoprotective, 
diuretic, anti inflammatory ,anti-stress and immunomodulation anti fertility, antimicrobial, 
antiviral, and insecticidal activities. In conclusion Boerhaavia diffusa contain biologically 
active compounds that may serve as candidate for new drugs in the treatment and 
prevention of human  live stock diseases.(84) 
 
 
26. Goyal.B.M et al., (2010) analyzed an overview of pharmacological potential of 
Boerhaavia diffusa. It covers various physiology, pathology of disease and their therapies. 
This article includes evidence based information regarding pharmacological activity of this 
plant. It has many ethanobotanical users and is medicinally used in the traditional 
Ayurvedic system.(85) 
 
27. Bhavin, A, et al., (2013)  investigated the effect of hydro alcholic extract of roots of 
Boerhaavia diffusa in experimental Beningn prostatic hyperplasia in rats. Body weight, 
prostate weight, bladder weight and serum testosterone were measured and histological 
studies were carried out. The result suggested that treatment with Boerhaavia diffusa may 
improve  symptoms of disease and inhibit the increased prostrate sign. Invitro study implies 
that herbal extract had  a beneficial effect on prostatic smooth muscles which relieve the 
urinary symptom and disease.(86) 
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28. Krishna murti, et al., (2001) evaluated antidiabetic activity of ethanolic extract of roots of 
Boerhaavia   diffusa against streptozocin induced experimental rats. Blood glucose level 
were determined on 0, 7th, 14, & 21st day after oral administration. The effect of ethanolic 
extract of B.diffusa on serum lipid profile like total cholesterol, triglycerides, LDl, VLDL, 
HDL were also measured in diabetic and non diabetic rats. The ethanolic extract of 
Boerhaavia diffusa was found to reduce blood sugar level in streptozocin induced diabetic 
rats. There was significant reduction in total cholesterol, LDL, VLDL, & improvement in 
HDL cholesterol in diabetic rats. The results indicated that Boerhaavia diffusa posses a 
hypoglyceamic & antihyperlipideamic effect.(87) 
 
29. Ajmire. P.V, etal.,( 2011) had conducted study of alcoholic & aqueous extract of whole 
plant of Boerhaavia diffusa against DMNO induced liver cirrhosis in rat’s model. The 
activity was assessed using ILS, histopathological studies of liver, biochemical & 
heamatological studies. EEBD & AEBD shows significant increase in survival time, a 
decrease in cirrhotic nodules. The biochemical & heamatological parameter were also 
corrected by EEBD & AEBD in DMN induced rats. However out of these two extract, 
EEBD shows maximum anti cirrhotic effect than AEBD.(88) 
 
 
30. Venkatesh. P, et al.,(2012) evaluated analgesic & antipyretic activity of various doses of 
alcoholic extracts of stem & leaves of Boerhaavia diffusa & leaves of Anisochilus 
carnosus. Tail immersion method & Hot plate in mice were studied for analgesic activity. 
Alcoholic extract of Boerhaavia diffusa had shown significant analgesic & antipyretic 
activity.(89) 
 
31. Mohammed Khalid, et al., (2012) had studied pharmacological evalution and qualitative 
analysis of Boerhaavia diffusa L. root. Various parameters like macroscopy, microscopy, 
fluorescence analysis as well as extraction value and qualitative phytochemical screening 
of different extraction were studied. The major components of extractions like total 
phenolic, total flavonoids were also estimated.(90) 
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32. Venkatesh. P, et al., (2012) evaluated a study on alcoholic extract of stem and leaves of 
Boerhaavia diffusa and leaves of Anisochilus carnosus on CCL4 induced hepatotoxicity in 
rats. Different dose levels administered. Biochemical parameters of liver like SGOT, 
SGPT, serum alkaline phosphatase, total and direct serum bilurubin were determined. It 
was concluded that the alcoholic extract of AEBD and AEAC possess hepato protective 
activity against CCL4 induced hepatotoxicity in rats.(91) 
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FOCUS OF THE PRESENT STUDY 
 
 
The present study was undertaken to find out  the potential activity of  Boerhaavia diffusa 
against breast cancer and their effects on MPTP induced breast Neurodegenaration in rats. 
 
From time immemorial mankind's efforts and ultimate aim have been to seek eternal 
happiness. And his endeavour has been to overcome and seek appropriate remedies for things 
that stand in his way. Plants have played a weighty role in maintaining human health and 
improving the quality of human life for thousands of years  and have several precious 
components of medicines, seasonings, beverages, cosmetics, and dyes. Herbal medicines are 
based on the premise that plants contain natural substance that can promote health and alleviate 
illness. In recent times focus on plant research has increased all over the world and large 
evidence has collected to show immense potential of medicinal plants used in various traditional 
systems. 
  
Today we are witnessing a great deal of public interest in the use of herbal remedies. 
Many western drugs had their origin in plant extract. There are many herbs, which are 
preponderantly used to treat cardiovascular problems, liver disorder, central nervous system, 
digestive system, metabolic disorders and for Neuroprotective effects. Given their potential to 
generate significant therapeutic effect, they can be useful as drug or supplement in the treatment 
in the management of many diseases. Herbal drug or medicinal plants, their extract and isolated 
compounds have demonstrated spectrum of biological activities. Such have been used and 
continued to be used as medicine in folk-fore or food supplement for various disorders. 
  
Boerhaavia diffusa (Punarnava) is one of the most famous medicinal plants in the 
treatment of a large number of human ailments is mentioned in Ayurveda, Charaka Samhita, and 
Sushrita Samhita. This work explains the evidence-based information regarding the 
pharmacological activity of this plant. It has many ethnobotanical uses (the leaves are used as 
vegetable; the root juice is used to cure asthma, urinary disorders, leukorrhea, rheumatism, and 
encephalitis). The Boerhaavia diffusa plant contains a large number of such compounds as 
flavonoids, alkaloids, steroids, triterpenoids, lipids, lignins, carbohydrates, proteins, and 
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glycoproteins. Punarnavine, boeravinone, hypoxanthine 9-L-arabinofuranoside, ursolic acid, 
punarnavoside etc. 
 
Now this investigation was undertaken to study the effect of  Boerhaavia diffusa on 
MPTP induced Neurodegenaration and also planned to study the changes occuring in the 
enzymic and non enzymic system such as super oxide dismutase, catalyase, glutathione peroxide 
and lipid peroxidation level present in the living body.  
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PLAN OF WORK 
 
 Induction of Parkinson’s syndrome in rats using MPTP injection by Intra 
peritoneally. 
 
 Evaluation of locomotor activity for the efficacy of drugs to decrease rigidity. 
 
 Evaluation of efficacy of drugs using elevated plus maze test to improve 
cognitive function. 
 
 Biochemical parameters include: 
 Lipid hydroperoxides 
 Catalase 
 Superoxide dismutase 
 Glutathione peroxidase 
 Total antioxidants 
 
 
 Histological examination of the midbrain region to evaluate the efficacy of 
drugs to decrease MPTP deterioration. 
 
 
 
 
 
 
 
Dr. D. Stephen,                                                     The American College, 
Lecturer                                         
Department of Botany            Madurai-2 
 
 
 
 
 
 
 
CERTIFICATE 
 
 
 
 
    This is to certify that the plant specimen brought to me by                     
Mr.NIRUBAN CHAKKARAVARTHI.G, Second year M. Pharm 
(Pharmacology); Student of K. M. College of pharmacy, Madurai has 
been identified as Boerhaavia diffusa linn  Belonging to the family 
Nyctaginaceae.  
 
 
 
 
 
Date ; 06/06/2014 
Madurai 
Tamil nadu 
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PLANT PROFILE 
 
 
Fig.No.14 
 Boerhaavia diffusa linn 
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Fig.No.15 
 Boerhaavia diffusa linn 
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Scientific Name       : Boerhaavia diffusalinn. Syn. B. repens; B. repens var.diffusa. 
Family                     : Nyctaginaceae. 
Family Name          :  Hog weed, Horse Purslane. 
TAXONOMICAL CLASSIFICATION: 
Kingdom           :    Plantae. 
Family               : Nyctaginaceae. 
Division            : Magnoliophyta. 
Class   : Magnoliopsida. 
Order                : Caryophyllales. 
Genus               :  Boerhaavia. 
Species             : B.diffusa. 
COMMON NAMES: 
Raktapunarnava, Shothaghni, Kathillaka, Kshudra, Varshabhu, Raktapushpa, Varshaketu, 
Shilatika. 
VERNACULAR NAMES: 
Bengali  :  Raktapunarnava. 
English   : Horse Purslene, Hog Weed. 
Hindi   :  Gadapurna, Lalpunarnava. 
Kannada  :    Sanadika, Kommeberu, Komma. 
Malayalam  : ChuvannaTazhutawa. 
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Tamil    : Mukurattai (Shihappu). 
Telugu   :  Atikamamidi, Erragalijeru. 
GEOGRAPHICAL DISTRIBUTION: 
Boerhaavia diffusais also indigenous to India; it is found throughout the warmer parts of 
the country up to an altitude of 2000 m in the Himalayan region. The genus Boerhaavia has 
several species, and is distributed in the tropical, subtropical, and temperate regions of the world. 
It is found in Australia, China, Pakistan, Sudan, Sri Lanka, Egypt, South Africa, USA and in 
several countries of the Middle East. Out of the 40 species of this genus, 6 species are found in 
India – B. diffusa, B. chinensis, B. erecta, B. repens, B.rependa, and B. rubicund. (92) 
ORIGIN AND HABITAT:  
Boerhaavia diffusais a perennial creeping weed, prostrate or ascending herb, up to 1 m 
long or more, havingthis is found throughout India. It grows up to an altitude of 70 centimeters 
especially during the rainy season. It has a large root system and produces yellow and white 
flowers. It can be found in many tropical and warm-climate countries. (93) 
USEFUL PARTS:         
Root, leaves & seeds, stem, flowers, fruits. 
 
DESCRIPTION:  
Boerhaavia diffusais a perennial creeping weed, prostrate or ascending herb, up to 1 m 
long or more, having spreading branches. 
 
The roots are very variable diffusely branched low spreading or creeping herbaceous 
perennial with an elongated fusiform or tapering tap root. The roots are stout and fusiform with a 
woody. 
 
The stems are numerous; 1-2 m long &the stem is prostrate, woody or succulent, 
cylindrical, often purplish, hairy, and thickened at the nodes. 
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Leaves are simple, thick, fleshy and hairy arranged in unequal pairs, green and glabrous. 
The shape of the leaves varies considerably ovate oblong, round or subcordate at the base and 
smooth above.  The leaves are simple, opposite, short petiolate, exstipulate, unequal in each pair, 
2.5-5 cm long by 1-4.5 cm wide, oblong or suborbicular, acute, obtuse or rounded at apex, 
cordate rounded or truncate at base, entire or wavy along the margin, subfleshy, glabrous or 
sparingly hairy above, silvery white beneath, petioles 0.7-3 cm long, slender, deeply grooved 
above.(94) 
 The flowers are small, regular, sessile or subsessile, pale rose to pink, in irregular clusters 
of 4-10, small umbels on extra axillary peduncles. (95) 
The fruits are very small, one seeded and enclosed in persistent lower half the perianth. 
The perianth is covered with sticky glandular hairs. (96) 
 
Part Boerhaaviadiffusa 
Plant A perennial herb from a fusiform root 
Leaves Opposite or sub-opposite, two of a node unequal, broadly ovate or sub-
orbicular, obtuse to rounded or sub-cordate at the base. 
Stem Prostrate, decumbent or ascending, 4-10 cm long, rather slender, 
divaricately branched 
Flowers In pendunculate, glomerulate clusters arranged in slender, long stalked, 
axillary or terminal corymbs 
Fruit Ovoid or sub-ellipsoid, rounded above, slightly cuneate, below, broadly and 
bluntly 5-ribbed, very glandular throughout 
Flowering and 
Fruiting 
Throughout the year in Indian conditions 
 
Table No.3 
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PHYTOCHEMICALS: 
Boerhaavia diffusa contains a large number of phytoconstituents, namely flavonoids , 
alkaloids, steroids, triterpenoids, lipids, lignins, carbohydrates proteins and glycoproteins. (97)  
 
 Plant also includes a series of rotenoids boeravinones from roots of the plant viz., 
Boeravinone (A-F)  
  Punarnavoside, a phenolic glycoside, is reportedly present in roots C-methyl flavone also 
has been isolated from Boerhaavia diffusaroots .(98,99) 
 Two known lignansviz.,liriodendrin and syringaresinol mono-β-D-glycoside 
isolated.(100,101) 
 Presence of a purine nucleoside hypoxanthine 9-L-arabinose, dihydroisofuroxanthone-
borhavine , phytosterols have been isolated from the plant.(102) 
 It contains about 0.04 % of alkaloids known as punarnavine and punernavoside an anti 
fibrinolytic agent.(103) 
 It also contains about 6 % of potassium nitrate an oily substance and ursolic acid. 
 The seeds of this plant contain fatty acids and allantoin and the roots contain alkaloids. 
  The green stalk of the plant has also been reported to contain boerhavin and boerhavic 
acid.(104) 
 
PHARMACOLOGICAL AND CLINICAL PROPERTIES OF B. DIFFUSA 
Various parts of B. diffusa are used for the treatment of numerous disorders in different 
parts of India. The root, leaves, aerial parts or the whole plant of B. diffusa have been employed 
for the treatment of various disorders in the Ayurvedic herbal medicine. The pharmacological 
studies have demonstrated that the roots of B. diffusa exhibit a wide range of properties such as  
hepato protectant.(105,106) anticonvulsant activity, immunomodulatory activity, It is clinically 
proved as a useful and safe drug in the patient of nephritic syndrome & cancer chemo preventive 
property against papillomagenesis. Potent antibacterial activity, diuretic, anti-inflammatory, 
antifibrinolytic, antibacterial, antistress agent, antihepatotoxic(107) anthelmintic febrifuge, 
antileprosy, anti-asthmatic, antiscabies, and anti-urethritis, and anti nematodal activity .(108,109) 
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pharmacological and clinical properties of Boerhaavia diffusa 
Fig.No.16 
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PHYTOCHEMICAL AND QUALITATIVE ANALYSIS 
 
EXTRACTION METHODS: 
  
 Whole plant of Boerhaavia diffusa were collected from Tamilnadu, kerala forest, 
shed dried for a week in a shadow and blended to coarse powder. 
 
 About 500gm of dried fine powder of Boerhaavia diffusa were soaked in the 
extractor and macerated for 30 hrs with petroleum ether .There it is reflexed successfully with 
chloroform,after that it is extracted with alcohol and water by continuous hot percolation method 
using soxhlet apparatus for 40hrs separately. Hydro alcoholic extracted was filtered and 
concentrated in vacuum using rotary flask evaporator under reduced pressure .After 
concentration hydro alcoholic extract of Boerhaavia diffusa given brownish residue stored in air 
tight container were subjected to qualitative test for identification of various plant constituents.   
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Dried whole plant of Boerhaavia diffusamaterial extracted by soxhletmethod 
                                               Marc-I 
 
        
      
 
        
     
 
      
 
 
  
 
 
 
 
 
 
 
                                             Extraction procedure. 
  
 
 
 
 
 
 
 
 
 
Marc-I Extracted with petroleum 
ether (30 hrs) 
Extracted with chloroform 
(40 hrs) 
Extracted with water (30%) + Ethanol 
(70%) 
(40 hrs) Marc-II 
Brownish colour  Residue 
Neuroprotective activity 
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PHYTOCHEMICAL INVESTIGATION OF EXTRACTS OF 
Boerhaavia diffusaLinn. 
 
All the extracts of leaf of Boerhaavia diffusa linn were subjected to various tests for 
identification of constituents. 
1) Detection of Carbohydrates: 
Small quantities of ethanolic and aqueous extract were dissolved in distilled water 
separately and filtered. The filtrates were taken for the various tests to detect the absence of 
carbohydrates. Absence of carbohydrate in Boerhaavia diffusa. 
A. Molisch’s Test: 
The filtrates were treated with 2-3 drops of 1% alcoholic - napthol and 2 ml.  of 
concentrated sulphuric acid was added along the sides of the test tube. A brown ring was 
observed. Ethanolic Boerhaavia diffusa plant extract showed the absence of sugar. 
B. Fehling’s Test: 
 Small portion of the filtrates were treated with equal volume of Fehling’s solution 
A and B and then heated. A brick red precipitate formed in alcoholic plant extract of 
Boerhaavia diffusa show absence of reducing sugar. 
C. Benedict’s Test: 
 Small portion of the filtrates were treated with equal volume of Benedict’s 
reagent. A yellow precipitate was formed in alcoholic extract Boerhaavia diffusa indicating 
the absence of reducing sugar 
D. Barfoed’s Test: 
Small portion of the both the plant extract was treated with Barfoed’s reagent.  Red 
precipitate was not formed in the ethanolic plant extract Boerhaavia diffusa. 
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E. Test for Starch:  
A small amount of the Boerhaavia diffusa ethanolic plant extract was treated with 
dilute iodine solution. No bluish black colour was observed in the both the plant extracts 
showing the absence of starch. 
2) Tests for Gums and Mucilage’s: 
Alcoholic precipitation and Molisch’s test. 
The, Boerhaavia diffusa plant extract was treated with absolute alcohol, stirred and 
filtered. The filtrate was dried and examined for its swelling properties. The extracts were 
answered for the presence of gums and mucilage.      
 
3) Test for Proteins and Amino Acids: 
 Small quantities of alcoholic extract was dissolved in few ml of distilled water and 
subjected to Ninhydrin test, Xanthoprotein test, test with tannic acid and heavy metals. 
 A.  Ninhydrin Test: 
Ethanolic extract of the both the plants were treated with ninhydrin reagent (0.1% 
solution) and boiled. Purple colour was observed indicating the presence of protein. 
 
B. Biuret Test: 
To a portion of the above prepared extracts, equal volumes of 5% w/v sodium 
hydroxide and 4 drops of 1% w/v copper sulphate solution were added. Violet colour was 
formed, indicating the presence of protein in the extract. 
C. Millon’s test of cole’s mercuric nitrite test: 
To the above-prepared extracts, millon’s reagent was added. White precipitate was 
formed, showing the presence of protein in the extract. 
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D. Xanthoprotein Test: 
To 3 ml of the above-prepared extracts, 1 ml of the concentrated nitric acid was added, 
boiled for one minute, cooled and concentrated ammonia was added till alkaline. An orange 
colour was not formed, showing the presence of protein in the extracts. 
4) Test for Fixed Oils and Fats: 
A. Spot Test: 
A small quantity of various extracts was pressed between two filter papers. Oil stains 
were observed with the extracts indicating the presence of fixed oils and fats. 
B. Saponification Test: 
Few drops of 0.5 N alcoholic potassium hydroxide was added various extracts along 
with of few drops of phenolphthalein. The mixture was heated on a water bath for one 
hour. Soap was formed with the extracts indicating the presence of fixed oils and fats. 
       5) Test for Alkaloids: 
Small amount of the solvent free ethanolic and aqueous extracts were separately 
stirred with a few ml of dilute HCl and filtered. The filtrates were tested with various 
alcoholic reagents. 
A. Mayer’s test : 
To the small quantities of the extracts, Mayer’s reagent was added. Presence of 
cream-colored precipitate indicates the presence of alkaloids in both the extracts. 
B. Dragendorff’s Test: 
To small quantity of extracts, Dragendorff’s reagent was added. Presence of orange 
brown precipitate indicates the presence of alkaloids in both plant extracts. 
C. Wagner’s Test: 
To small quantity of the extracts, Wagner’s reagent was added. Presence of 
reddish brown precipitate, indicate the presence of alkaloids in Boerhaavia diffusa extract  
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D. Hager’s Test: 
To small quantity of the extracts, Hager’s reagent was added. Presence of yellow 
precipitate, indicate the presence of alkaloids in Boerhaavia diffusa extract. 
6) Tests for Glycosides: 
A small amount of the different extracts were dissolved separately in 5 ml of 
distilled water and filtered. Another portion of the extracts were hydrolyzed with 
hydrochloric acid for one hour on a water bath and hydrolyzate was subjected to Legal’s, 
Baljet’s, Borntrager’s, Keller-Killani’s tests and for the presence of cyanogenetic 
glycosides. 
A. Legal’s Test: 
 To the hydrolyzate, 1 ml of pyridine and a few drops of sodium nitroprusside 
solution was added and then made alkaline with sodium hydroxide solution. Pink colour 
was observed in Boerhaavia diffusa extract. 
B. Baljet’s Test: 
To a section of plant extract, sodium picrate solution was added. Yellowish 
orange colour was observed in Boerhaavia diffusa extract. 
C. Borntrager’s Test: 
Hydrolyzed was treated with chloroform and the chloroform layer was separated. 
To this, equal quantity of dilute ammonia solution was added. Pink colour was not 
observed in the ammonical layer of chloroform and both the extracts showed the absence 
of glycosides. 
   D. Test for Deoxy Sugar (Keller-Killani Test): 
To the different extracts 10 ml of 70% alcohol were added, boiled on a water 
bath, filtered. The filtrates were diluted with 1 ml of distilled water; 1ml of strong lead 
acetate solution was added and filtered. The filtrates were extracted with an equal volume 
                                                            PHYTOCHEMICAL AND QUALITATIVE ANALYSIS 
 
NEUROPROTECTIVE EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA LINN 
AGAINST MPTP INDUCED NEURODEGENARATION IN RATS  65 
 
of chloroform. The chloroform layer was pipetted out and evaporated to dryness. The 
residue obtained was dissolved in 3 ml of 3.5% of ferric chloride in glacial acetic acid, 
left for one minute and then transferred to a test tube. To the side of the test tube, 1.5 ml 
of sulphuric acid was added carefully, which formed a separate layer at the bottom and 
kept for few minutes. 
Blue colour at the interface and pale green colour in the upper layer was not 
observed in any of the extracts indicating the absence of cardiac glycoside. 
7) Test for Phytosterols: 
 Small quantities of the various extract were dissolved in the 5 ml of chloroform 
separately. Then these chloroform solutions were subjected to Libermann’s test, 
Libermann-Burchard’s test, Salkowski’s test. 
A. Libermann-Burchard’s Test: 
The residue was dissolved in chloroform. To this Libermann-Burchard’s reagent was 
added. Green colour was produced in both the extract indicating the presence of 
phytosterols. 
B. Salkowski’s test: 
A few drops of concentrated sulphuric acid were added to chloroform solution. The lower 
layer of the solution turned brownish red colour with both the extracts indicating the 
presence of phytosterols. 
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8) Test for Flavanoids: 
The different extracts were separately dissolved in ethanol and then subjected to the 
following tests. 
A. Ferric chloride Tests: 
To a small quantity of the ethanolic extract, few drops of neutral ferric chloride were 
added. Blackish red colour was observed in Boerhaavia diffusa extract indicating the 
presence of flavonoids. 
B. Shinoda’s test: 
A small quantity of the extract was dissolved in alcohol and to this magnesium 
metal followed by concentrated   hydrochloric acid, was added drop wise and heated.  A 
magenta colour was produced in Boerhaavia diffusa extract indicating the presence of 
flavonoids. 
C. Flavones: 
1. With sodium hydroxide solution, the extract gave yellow colour. 
2. Ethanolic extract gave orange colour with concentrated sulphuric acid. 
 
9) Test For Tannins: 
The extracts were dissolved in water and filtered. The filtrates were treated with 
various reagents.  
A. Ferric chloride test: 
Few ml of the filtrates were treated with 5% ferric chloride solution. A bluish black 
colour was observed indicating the presence of tannins in both the extracts. 
B. Reaction with lead acetate: 
Few ml of the filtrates were treated with lead acetate solution. White precipitates 
were produced in Boerhaavia diffusa extract indicating the presence of tannins. 
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C. Gelatin Test: 
The extract were dissolved separately in minimum amount of water and filtered. 
To the filtrate, add 1 ml of 1 %solution of gelatin. Both the extract did not produce any 
white precipitate. 
TABLE .NO:4 
QUALITATIVE CHEMICAL ANALYSIS OF ETHANOLIC EXTRACT OF  
Boerhaavia diffusaLinn. 
SI.NO Test for plant constituents Boerhaavia 
diffusaLinn. 
 Test for alkaloids  
1    a. Mayer's Test + 
    b. Dragendorff's Test + 
    c. Wagner's Test + 
    d. Hager's Test + 
 Test for Glycosides  
    a. Legal's Test + 
2    b. Baljet's Test + 
    c. Borntrager's Test + 
    d. Keller-Killani's Test + 
 Test for Flavanoids  
3    a. Ferric chloride Test + 
    b. Shinoda's Test + 
    c. Fluorescence Test + 
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    d. Reaction with alkali and acid + 
 Test for Tannins and Phenolic Compounds  
4   a.  5% Ferric chloride solution test + 
   b.  Reaction with lead acetate + 
   c.  Gelatin test _ 
 
Test for Proteins and amino acids 
 
 
5    a. Ninhydrin Test + 
    b. Biuret Test + 
    c. Millon's test or Cole's Mercuric Nitrate 
test 
+ 
    d. Xanthoprotein test + 
 Test for Carbohydrates  
6   a. Molisch's test - 
   b. Fehling’s test - 
   c. Benedict's test - 
   d. Barfoed's test - 
   e. Test for Starch - 
 Test for Gums and Mucilage  
7 Alcoholic precipitation and Molisch's test + 
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PHARMACOLOGICAL EVALUATION 
 
In today’s life of stress and strain the need for agents having neuroprotective 
and neuropharmacological activity increasing for enhancing learning and memory 
function of the brain.(110) Stress involves complex biochemical, neural and 
immunological mechanism and play a crucial role in the genesis/progression of a 
variety of disease states  ranging from psychiatric diseases cardiovascular diseases, 
hypertension, peptic ulcers, migraine, allergies, asthma, carcinoma, rheumatic  
diseases  and ulcerative colitis.(111) The ancient system of medicine (Ayurveda) is  a 
treasure of medicinal plants as herbal remedies, to prevent or treat diseases. The plant 
Boerhaavia diffusa Linn reported to possess strong  neuroprotective effects.   
 
MATERIALS AND METHODS 
MATERIALS 
1. 1- methyl -4 phenyl-1,2,3,6 –tetrahydropyridine(MPTP- neurotoxin from 
Sigma Aldrich, Saint Louis,MO, USA). 
2. Ketamine from Neon Pharmaceuticals. 
3. Boerhaavia diffusa Linn were collected from Tamilnadu, kerala forest, shed 
dried for a week in a shadow and blended to coarse powder. 
 
ANIMALS 
 Male Wistar rats weighing 200-250 gm. 
 The rats were maintained in a controlled room temperature (25±20C) on 12 
hr light–dark cycles (lights on 7.00 am) with free access to food and water 
ad libitum in central animal house at K.M. College of Pharmacy animal 
house. 
 The studies were conducted accordance with the Ethical Committee and all 
the animals were sacrificed by euthanasia method. 
 The rats were placed in poly propylene cages with three animals per cage 
and were allowed to acclimatize one week prior to treatments. 
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METHODS 
 MPTP was purchased from Sigma Aldrich, Saint Louis, MO, USA. 
 The standardized Hydroalcoholic extract of Boerhaavia diffusa Linn bought 
from Tamilnadu, kerala forest, shed dried for a week in a shadow and blended 
to coarse powder. 
 MPTP (20mg/kg) was dissolved in normal saline solution and administered 
through I.P route. 
 Hydroalcoholic extract of Boerhaavia diffusa linn extract is dissolved in 0.9% 
saline orally for 21 days. 
 Both MPTP and Hydroalcoholic extract of   Boerhaavia diffusa Linn extract 
continued for 21 days. 
 
TREATMENT PROTOCOL               
The rats were segregated into five groups. Each group have six rats. 
 
  GROUP I :  Served as Normal control and received normal saline  
(10ml/kg, orally). 
  
  GROUP II :  Served as Perse control received 250mg/kg body weight of  
Hydroalcoholic Extract of Boerhaavia diffusa Linn orally for 
period of 21 days. 
 
GROUP III :  Served as toxic control received 20mg/kg body weight of  
MPTP administered through intraperitoneally.         
                          
GROUP IV :  Served as treatment control received 20mg/kg body weight of  
MPTP administered through  intraperitoneally and        
200mg/kg body weight of Hydroalcoholic extract of 
Boerhaavia diffusa Linn  orally administered for 21 days. 
 
GROUP V :  Served as treatment control received 20mg/kg body weight of  
MPTP administered through intraperitoneally and 400mg/kg 
body weight of Hydroalcoholic extract of Boerhaavia diffusa 
Linn orally administered for  21 days. 
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BEHAVIOURAL STUDIES 
All behavioural studies were started 2 weeks after MPTP treatment.(112) The 
behavioural studies was performed between 10 .00am -2.00 pm in a laboratory at a 
standard optimal conditions. All experiments were performed and analysed by a 
subject blind to experiment. 
 
ELEVATED PLUS MAZE TEST: 
PROCEDURE:  
The elevated plus maze consisted of two opposite black open arms (50 × 10 
cm), crossed with two closed walls of the same dimensions with 40 cm high walls. 
The arms were connected with a central square of dimensions 10 × 10 cm. The entire 
maze was elevated to a height of 50 cm from the floor. Acquisition of memory was 
tested on day 13 after MPTP administration. Animal was placed individually at one 
end of the open arm facing away from the central square. The time taken by the 
animal to move from the open arm to the closed arm was recorded as the initial 
transfer latency (ITL). Animal was allowed to explore the maze for 20 seconds after 
recording the ITL and then returned to the home cage. If the animal did not enter the 
enclosed arm within 90 seconds, it was guided on the back into one of the enclosed 
arm and the ITL was given as 90 seconds. Retention of memory was assessed by 
placing the rat in an open arm and the retention latency was noted on day 14 and day 
21 of ITL and was termed as the first retention transfer latency (1st RTL) and second 
retention transfer latency (2nd RTL), respectively.(113) 
 
TREATMENT PROTOCOL: 
G1:  Served as Normal control and received normal saline (10ml/kg, orally). 
G2:  Served as Perse control received 250mg/kg body weight of 
Hydroalcoholic Extract of Boerhaavia diffusa Linn  orally for period of 
21 days. 
G3:  Served as toxic control received 20mg/kg body weight of MPTP  
administered through intraperitoneally. 
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G4:  Served as treatment control received 20mg/kg body weight of     
MPTP, intraperitoneally and 200mg/kg body weight of  
Hydroalcoholic    extract of Boerhaavia diffusa Linn 200mg/kg  orally 
and administered for 21   days. 
 G5:  Served as treatment control received 20mg/kg body weight of MPTP,  
Intraperitoneally and 400mg/kg body weight of Hydroalcoholic extract       
of Boerhaavia diffusa Linn 400 mg/kg orally administered for 21 days. 
LOCOMOTOR ACTIVITY 
The locomotor activity was measured using an Actophotometer. The 
movement of the animal cut off a beam of light falling on photocell and count was 
recorded and displaced digitally.  
 
PROCEDURE 
Each rat was placed individually in the actophotometer for 10 minutes and 
basal activity scores were recorded .Gross behavior activity was observed on 14th and 
21st day after MPTP injection .The animals were observed for a period of 10 minutes 
and the values were expressed as counts/10min.(114) 
TREATMENT PROTOCOL: 
G1:  Served as Normal control and received normal saline (10ml/kg, orally). 
  
G2:  Served as Perse control received 250mg/kg body weight of Hydroalcoholic 
Extract of Boerhaavia diffusa Linn  orally  for period of 21 days. 
 
G3:  Served as Toxic control received 20mg/kg body weight of MPTP 
intraperitoneally. 
 
G4:  Served as Treatment control received 20mg/kg body weight of MPTP 
intraperitoneally and 200mg/kg body weight of  Hydroalcoholic extract of 
Boerhaavia diffusa Linn  orally and administered for 21 days. 
G5:  Served as Treatment control received 20mg/kg body weight of MPTP       
intraperitoneally and400 mg/kg body weight of  Hydroalcoholic extract of 
Boerhaavia diffusa Linn orally administered for 21 days. 
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BIOCHEMICAL EVALUATIONS 
On completion of experimental period, animals are sacrificed by euthanasia 
under ketamine Anaesthesia. Brain tissues are excised immediately and immersed in 
ice cold saline. The tissues were homogenized using homogenizer. The homogenate 
was centrifuged at 12000 rpm for 20 minutes, 40◦C to obtain the post mitochondrial 
supernatant (PMS) which was used for further analysis. 
ESTIMATION OF GLUTATHIONE PEROXIDASE 
Glutathione peroxidase is an enzyme found in cytoplasmic and mitochondrial 
fraction of cells which catalyse the reduction of hydrogen peroxide by reduced 
glutathione and function to protect the cells from oxidative damage. The 
determination of Glutathione peroxidase using ELISA kits measures GPx indirectly by 
a coupled reduction with glutathione reductase. Oxidised Glutathione (GSSG) 
produced upon reduction of hydroperoxide by GPx is recycled to its reduced state by 
GR and NADPH.(115) 
                                         
                 ROOH+2GSH  ROH+GSSG+H2O 
           
 GSSG+NADPH+H+   2GSH+NADP+ 
 
The oxidation of NADPH to NADP+ is monitored spectrophotometrically by 
a decrease in Absorbance at 340 nm (A340). Under conditions in which the GPx 
activity is rate limiting, the rate of decrease in the A340 is directly proportional to the 
GPx activity in the sample. By means of these kits we can determine all of the 
glutathione dependent peroxides in plasma, erythrocytes, lysates and tissues 
 
ESTIMATION OF SUPEROXIDE DISMUTASE 
Superoxide dismutase is metalloenzymes that catalyse the dismutation of 
superoxide into hydrogen peroxide and molecular oxygen and provide an important 
defense mechanism against superoxide radical toxicity. 
 
A common indirect method for SOD utilizes nitroblue tetrazolium conversion 
to NB+ diformazan (formazan dye) via superoxide radical.The rate of reduction with 
GPX
GR
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O2- is related to XO activity and inhibited by SOD.IC50 can be detected by 
colourimetry by using absorbance at 440nm.(116) 
 
ESTIMATION OF TOTAL ANTIOXIDANTS 
 Reactive oxygen species may be obtained as side products of mitochondrial 
oxidative phosphorylation utilized by brain. Excess production of reactive oxygen 
species causes oxidative stress. The antioxidant systems include enzymes such as 
Superoxide dismutase, Catalase, glutathione peroxidase, macromolecules such as 
albumin, ceruloplasmin, ferritin and array of small molecules such as Ascorbic acid,α-
Tocopherol, β-carotene. The sum of the endogenous and food derived antioxidants 
represent total antioxidant capacity of the system. 
 
ELISA kits can be used to measure the total antioxidant capacity of serum, 
urine, saliva or cell lysates. 
 
           The principle involved in this assay is ability of antioxidants in the sample to 
inhibit the oxidation of ABTS (2-2’ azino-di [3 ethyl benzthiazoline sulphonate] to 
ABTS + by metmyoglobin. The amount of ABTS+ produced can be monitored by 
reading the absorbance at 750nm or 405 nm.(117)  Under the reaction condition used 
the antioxidants of the sample cause suppression of absorbance at 750nm or 405 nm 
to a degree which is proportional to concentration. 
 
ESTIMATION OF CATALASE 
Catalase is a ubiquitous antioxidant enzyme which is involved in the 
detoxification of hydrogen peroxide (H202), a reactive oxygen species which is a toxic 
product of both normal aerobic metabolism and pathogenic ROS production. 
       Catalase 
             2H2O2 O2+2H2O 
                           Catalase 
            H2O2+AH2  A+2H2O 
         
              This assay utilizes the peroxidative function of CAT for determination of 
enzyme activity, which is based upon the reaction of enzyme with methanol in the 
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presence of an optimal concentration of H2O2. The formaldehyde produced is 
measured colorimetrically with 4-amino 3 hydrazino 5 mercapto-1, 2, 4 triazole.(118) 
       
ESTIMATION OF LIPID HYDROPEROXIDES 
 
               Lipid peroxidation, a major indicator of oxidative stress measured by using 
thiobarbituric acid substance.(119) This method is utilized for assaying samples such as 
drugs, food products and human and biological tissues. It provides important 
information regarding free radical activity in diseases and used for measurement of 
antioxidant activity of several compounds. The principle involved in this assay is 
Malonidialdehyde (MDA) forms a 1:2 adduct with thiobarbituric acid and produces 
the compound which can be measured by flurimetry. 
 
HISTOPATHOLOGICAL EXAMINATION: 
 
              Mid portion of the brain specimens obtained from all groups of animals were 
fixed in 10% formalin. The tissue sections were embedded in Paraffin wax and 
sectioned at 5-6μm thickness and sections were stained with Haematoxylin and eosin 
method for photomicroscopic observation of the brain histopathological 
architecture.(120) 
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                                                     RESULTS 
 
Effect of Hydroalcoholic extract of Boerhaavia diffusa Linn (HAEBD) on LPO in 
MPTP Treated rats  
Systemic administration of MPTP causes significant rise in brain LPO                   
(Lipid hydroperoxides) levels in MPTP treated groups (G3) compared to control 
groups (G1) at P<0.01.In groups treated with  (HAEBD)  alone there is no significant 
change in LPO levels (P>0.05).In groups treated with both doses of  (HAEBD) 
(200mg and 400mg/kg) along with MPTP, there was a significant decrease (p<0.01) 
in LPO levels. (Table. 5) (Chart.1) 
 
 
Effect of Hydroalcoholic extract of Boerhaavia diffusa Linn (HAEBD)  on SOD 
in MPTP treated  rats 
Brain homogenate tissue SOD levels were significantly decreased in MPTP 
treated animals in (Group 3) compared to control groups (G1) at (p<0.01).In groups 
(G2) animals treated with HAEBD alone there is no significant change in SOD 
levels.but treatment with both doses of  HAEBD   200mg/kg and 400mg/kg in Group 
4 &5 significantly increased the SOD levels after 21 days (p<0.01). (Chart.2) 
 
Effect of Hydroalcoholic extract of Boerhaavia diffusa Linn (HAEBD) on 
catalase in MPTP treated rats 
There was statistically significant decrease in Catalase levels after MPTP 
treatment for 21 days (p<0.01).  HAEBD  alone did not change significant catalase 
levels(p>0.05). But HAEBD  administered for 21 days along with MPTP was able to 
increase the CAT levels more than MPTP alone(p<0.01). (CHART.3) 
 
Effect of Hydroalcoholic extract of Boerhaavia diffusa Linn (HAEBD)  on 
glutathione peroxidase (GPX) in MPTP treated rats 
HAEBD alone when administered at a dose of 250mg/kg, no significant 
change in GPx levels (p>0.05). But MPTP treatment decrease the GPX levels 
significantly (p<0.01) and treatment with  HAEBD  at both doses (200mg/kg and 
400mg/kg) along with MPTP was able to increase the GPx levels. Brain tissue 
homogenates GPX level reached near normal in both groups treated with  HAEBD 
(p<0.01). (CHART.4) 
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Effect of Hydroalcoholic extract of Boerhaavia diffusa Linn (HAEBD)  on total 
antioxidants (TA) in MPTP treated rats 
There was a significant decrease in total antioxidants (TA) levels after 
exposure of rats to MPTP (p<0.01) for 21 days. Concurrent treatment with HAEBD  
at two doses 200mg/kg and 400mg/kg significantly increased total antioxidant levels 
(p<0.01).but in groups (G2) animals treated with HAEBD  alone there is no 
significant change in TA levels. (p>0.05). (CHART.5) 
  
Effect of  improved on Behavioural alteration in MPTP treated rats  
     Elevated plus maze:  
In the present experiment, mean initial transfer latencies (ITL) on day13 for 
each rat was relatively stable and showed no significant variation among different 
groups. All the rats entered the closed arm within 90 seconds Following training, 
normal control, MPTP injected, and Hydro alcoholic extract of Boerhaavia diffusa 
Linn (HAEBD)  treated (200mg and 400mg/kg) rats entered closed arm quickly as 
compared to MPTP treated rats. Mean retention transfer latencies (1st RTL and 2nd 
RTL) to enter closed arm on day 14 and 21 were shorter as compared to ITL on day 
13 of each group, respectively. In Contrast, MPTP injected rats performed poorly 
throughout the experiment and did not show any change in the Mean retention time 
transfer latencies on day14 and 21 as compared to the pre training latency on day 
13,demonstrating that MPTP induced marked memory impairment. 
 
Chronic Administration of Hydroalcoholic extract of boerhaavia diffusa Linn 
(HAEBD)  (200mg&400mg/kg) beginning prior to MPTP injection significantly 
decreased mean retention latencies on day 14&21 following MPTP injection. 
(p<0.01).  
 
The mean transfer latencies of Hydroalcoholic extract of boerhaavia diffusa 
Linn (HAEBD)  treated (200mg/kg&400mg/kg p.o) and MPTP treated groups were 
significantly different from that of HAEBD perse groups on day 14&21. (p<0.05). 
(Table.6) 
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Effect of Hydroalcoholic extract of boerhaavia diffusa Linn (HAEBD)  on 
locomotor activity 
In the present series of experiments the mean scores of locomotor activity for 
each rat were more relatively stable and showed no significant variation among 
different groups. The mean scores in normal control, perse control and MPTP treated 
rats remain unchanged. Further, both the dose of Hydroalcoholic extract of 
boerhaavia diffusa Linn (HAEBD)  (200mg&400mg/kg) did not cause any significant 
activations in the locomotor activity as compared to MPTP treated rats on day 14&21. 
(Table.7) 
 
Histological examination of the Rat’s brain 
 
 Fig no: 17 Section of brain from rats treated with Normal Saline for 21 days 
showing normal architecture. 
 Fig no: 18    Section of brain from rat treated with 250mg/kg body weight of 
Hydroalcoholic extract of boerhaavia diffusa Linn (HAEBD)  for 21 days 
(perse control) showing normal architecture. 
 Fig no: 19  section of brain from rats treated with MPTP for 21 days showing 
pathological changes like cellular inflammation, vascular degeneration and 
cytoplasmic vacuolation. 
 Fig no:20 & 21 section of brain from rats treated with MPTP for 21 days 
followed by Hydroalcoholic extract of boerhaavia diffusa Linn (HAEBD)  
treatments showing marked reduction of degeneration and vacuolation. 
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  BIOCHEMICAL PARAMETERS 
 
Table.5:-EFFECT OF HAEBD ON ANTIOXIDANT STATUS IN HOMOGENENATE   OF 
BRAIN TISSUES 
 
 
 
Values are expressed as Mean±SEM. 
Values were found out by using one way ANOVA followed by Newman Keul’s multiple range 
tests. 
   a **-Values are significantly different from Normal control  at P<0.01. 
   b*-Values  are significantly different from Toxic control  at P<0.05. 
   b**-Values are significantly different from Toxic control at P<0.01. 
 
  
GROUPS 
Lipidhydroperoxide 
LPO(nmol/mg of 
protein) 
Total 
antioxidants 
TA(mM/mg of 
protein) 
Glutathione 
Peroxidase 
GPx(nmol/min
/mg of 
protein) 
Catalase 
CAT(μM/ 
mg of 
protein) 
Superoxide 
dismutase(units
/mg of protein) 
GROUP I 
 
3.03±0.05** 
 
3.10±0.07** 22.23±0.83**  46.45±1.15** 
 
35.58±1.19 
 
GROUP II 
 
2.48±0.04 
 
 3.23±0.08  27.34±0.99  52.94±0.95 33.21±0.71 
GROUP III 4.35±0.10   1.6±0.07  12.45±0.58 32.19±1.14     9.87±0.82 
 
GROUP 1V 
 
2.14±0.11** 2.41±0.04**  20.37 ±0.97**  45.45±0.61**     20.03±0.84 
 
GROUP V 
 
2.52± 0.05**  2.6±0.16 22.03±0.70** 46.76±0.77**   23.26±0.69** 
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Table.6:-EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA 
DIFFUSA LINN (HAEBD) ON MEMORY PERFORMANCE IN ELEVATED 
PLUS MAZE PARADIGM IN MPTP INJECTED RATS. 
 
 
Values are expressed as Mean± SEM 
Values were found out by using one way ANOVA followed by Newman Keul’s multiple 
range tests. 
*a-Values were significantly different from Normal and Perse Control at p<0.01. 
*b -Values were significantly different from MPTP treated groups at p<0.05. 
 
 
 
GROUPS 
 
TREATMENT 
  
MEAN TRANSFER LATENCY 
ITL ISTRTL 2nd RTL 
GROUP I Normal control (10ml/kg Normal saline) 
 
60.48±0.483 
 
21.61±0.31** 
 
22.58±0.62** 
GROUP II 
Perse control 
( Extract alone-250mg/kg body 
weight HAEBD)
 
63.47±0.75 
 
20.06±0.44 
 
18.44±0.58 
GROUP III Toxic control (20mg/kg  body weight of MPTP) 
 
68.61±0.59 
 
82.03±1.34 
 
80.57±1.20 
GROUP 1V 
 
Treatment control 
(20mg/kg body weight of 
MPTP+200mg/kg  body weight of 
HAEBD ) 
 
64.84±0.46** 
 
48.32±1.42** 
 
41.90±1.10 
GROUP V 
 
Treatment control(20mg/kg body 
weight MPTP +400mg/kg body 
weight of HAEBD ) 
 
66.21±0.55* 
 
38.40±0.93* 
 
35.27±0.80** 
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TABLE .7:- EFFECT OF HYDROALCOHOLIC EXTRACT OF 
           BOERHAAVIA DIFFUSA  LINN  (HAEBD)   ON  LOCOMOTOR    ACTIVITY 
 
 
 
Values are expressed as Mean±SEM 
Values were found out by one way ANOVA followed by Newmann Kaul’s Multiple range test 
Values were not significantly different from each group. 
 
 
 
GROUPS TREATMENT 
Locomotor activity (score) in 10 min±SEM 
on 
14th day 21st day 
GROUP I Normal Control 216.06±1.61* 222.18±1.46** 
 
GROUP II 
 
Perse Control 
 
203.84±1.92 
 
216.13±1.76 
 
GROUP III 
 
Toxic Control 
 
221.49±1.69 
 
236.60±1.60 
GROUP IV 
 
Treatment control 
 
200.39±1.94** 
 
226.57±1.86* 
 
     GROUP V 
 
     Treatment control   231.75±1.08**       229.42±2.01* 
OBSERVATION & RESULTS  
 
 NEUROPROTECTIVE EFFECT OF HDROALCOHOLIC EXTRAT OF BOERHAAVIA DIFFUSA  LINN AGAINST MPTP 
INDUCED NEURODEGENARATION IN RATS   82 
 
 EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA LINN   
                                                               (HAEBD)  
                                                  ON LIPID HYDROPEROXIDES 
 
   
                                               CHART1 
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 EFFECT OF  HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA 
(HAEBD) 
SUPEROXIDE DISMUTASE      
 
CHART 2 
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EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA 
(HAEBD) 
ON CATALASE 
                
CHART 3 
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EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA 
(HAEBD) 
ON GLUTATHIONE PEROXIDASE 
 
      
CHART 4             
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  EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA 
(HAEBD) 
                                    TOTAL ANTIOXIDANTS 
 
      
CHART 5 
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                                              HISTOPATHOLOGICAL   EXAMINATION 
G1: NORMAL CONTROL (10ml/kg Normal saline) 
 
 
FIG NO:17 
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                                                G2: PERSE CONTROL (Extract alone-250mg/kg) 
 
 
 
FIG NO:18 
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G3: TOXIC CONTROL (MPTP alone-20mg/kg) 
 
                            
Fig No:19 
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G4: TREATMENT CONTROL 
(20mg/kg MPTP+200mg/kg 
HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA (HAEBD) 
 
 
 
Fig no ;20 
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                                                    DISCUSSION  
          
              MPTP is a neurotoxin that produces a parkinsonian syndrome in both humans and 
experimental animals.(121)  In the present study, the administration of MPTP significantly results 
in  oxidative damage and mitochondrial dysfunction  in  brain. Furthermore, MPTP is rapidly 
converted to the hydrophilic metabolite 1-methyl-4-phenylpyridinium (MPP+) by MAO-B in 
astrocytes.(122) MPP+ is selectively accumulated by high affinity dopamine transporters (DAT) 
and taken up into the mitochondria of dopaminergic neurons, where it disrupts oxidative 
phosphorylation by inhibiting complex I (NADH-ubiquinone oxidoreductase) of the 
mitochondrial electron transport chain.(123) This leads to impairment of ATP production, elevated 
intracellular calcium levels, and free radical generation, thereby exhibiting dopaminergic 
neurotoxicity.(124) Therefore, MPTP treatment is known to cause a marked depletion of dopamine 
and nigrostriatal neuronal cell death in a wide variety of animal species, From these findings, we 
suggest that the dopamine depletion caused by the acute treatment with MPTP in rats is 
accompanied by sustained nigral degeneration.(125) Daily administration of Boerhaavia diffusa 
Linn extract at the dose of 200 mg/kg and 400 mg/kg p.o. reversed these behavioral and 
biochemical alteration induced by MPTP. The possible mechanism of neuroprotection conferred 
by Boerhaavia diffusa in behavioral and neurochemical parameters is the reduction of the 
oxidative stress caused by MPTP. 
                 
             Glutathione a potent  antioxidant, plays an important role in the dopamine and 
pathogenesis of Parkinson’s disease presenting in the reduced form within the cells. It has been 
shown to react with free radicals and prevent generation of hydroxyl free radicals [1. Treatment 
with MPTP also leads to reduced activity of GPx and decreased levels of the essential pyridine  
nucleotide  NAD+, ATP, and  GSH  in primary  human neurons after a 24-hour exposure. The 
maintenance of  GPx  activity appears crucial for the  maintenance  of cell viability during 
oxidative  insult.(126-129) 
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               MPTP treated rats shows highly significant increase in LPO levels in brain tissue  
homogenate. There was also a significant decrease in TA levels with MPTP treatment. The 
differences in the level of LPO products observed in various brain regions may be attributed to 
the differences in their iron content and diverse metabolism, which influence the generation of 
ROS. Certain  brain regions like striatum and hippocampus are highly enriched with non-heme 
iron, which is catalytically involved in the production of ROS.(130)Exposure to MPTP might have 
lead to the  peroxidation of membrane lipids eventually leading to the loss of membrane integrity 
and finally lead to cell death in these brain regions.   
                 
 During oxidative stress in the neuronal cells there is an increase in intracellular calcium 
levels in the brain.(131)This increased intracellular calcium levels can induce the irreversible 
conversion of Xanthine dehydrogenase (XDH) to XO, which in turn catalyzes the oxidation of 
Xanthine to provide a source of oxygen. In addition, auto-oxidation of dopamine in brain could 
also serve as a source of superoxide anion.(132)These mechanism could be the main reasons for 
the increased levels of XO and reduction in activity of SOD leading to an overload of oxygen 
radicals and repression of antioxidant enzymes with MPTP exposure. Oxidation of L- 3,4-
dihydroxyphenylalanine (L-DOPA) and dopamine (DA) to generate semiquinones/Quinones, 
oxygen radicals and other ROS may play a vital role in neuronal cell death in Parkinson’s 
disease. 
MDA is widely used to assess lipid peroxidation both in vitro and in vivo.(133) However, it 
is likely that MDA can form complexes with other biological components such as protein, lipids, 
and nucleic acids which can contribute to an underestimation of endogenous lipid 
peroxidation.(134) On the contrary to our lipid peroxidation data, we also show that MPTP can 
lead to distinct alterations in endogenous antioxidant defense mechanisms. MPTP treatment has 
been previously shown to significantly increase Mn-SOD and CuZn-SOD activities in the 
striatum of  rats which is suggestive of acute oxidative stress insult.(135) SOD is upregulated in 
cells when O2•− is produced in excessive levels.(136)This observation suggests that SOD may play 
a role in the toxicity observed following acute treatment of MPTP, although ROS formation may 
not play a major role in MPTP-induced toxicity. We also observed a significant increase in CAT 
after a 24-hour treatment with MPTP. CAT is an enzyme that is involved in the detoxification of 
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ROS and the elimination of hydrogen peroxide (H2O2) in particular.(137)The increase in both 
intracellular SOD and CAT activities may therefore represent an adaptive response due to the 
leakage  of free  radicals during  impaired  mitochondrial  respiration. Taken together, our data 
suggests that MPTP exposure can limit the endogenous antioxidant defense, subsequently 
increasing the vulnerability of neuronal cells to additional oxidative stress. An imbalance in the 
function of endogenous antioxidant defense mechanisms can lead to the accumulation of free 
radicals and ROS and increased susceptibility to oxidative stress, which contributes to the 
pathogenesis of PD. 
 Further, histological examination revealed that MPTP administration showed 
significant alterations in the neuronal architecture of striatum. Also, MPTP-induced lesions were 
present in large number, which are similar to the clinical anatomical abnormality seen in the 
Parkinson’s disease patients.(138)HAEBD  treatment prevented these neuro-architectural changes. 
Thus, it confirms Hydroalcoholic Extract of Boerhaavia diffusa offered protection to the 
dopaminergic neurons by preventing the histological changes induced by MPTP. Thus the 
Boerhaavia diffusa Linn extract at the dose of 200 & 400mg/kg p.o. showed a significant 
Neuroprotective activity  
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                                                 CONCLUSION  
                    
                 In summary, findings of the present study provide evidence that HAEBD at the dose 
of 400mg/kg p.o alleviates behavioral deficits. It also reduced the oxidative parameter and 
enhances the brain antioxidants, significantly prevents the brain from neurotoxic effects. 
Therefore, Hydroalcoholic extract of Boerhaavia diffusa Linn contains flavanoids and 
polyphenols was considered as powerful neuroprotective agent could offer a useful support to the 
Parkinsonism therapy. 
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